Next Article in Journal
Nutrition for European Elite Fencers: A Practical Tool for Coaches and Athletes
Next Article in Special Issue
Benefits of Puerarin on Metabolic Syndrome and Its Associated Cardiovascular Diseases in Rats Fed a High-Fat/High-Sucrose Diet
Previous Article in Journal
Quercetin Regulates Lipid Metabolism and Fat Accumulation by Regulating Inflammatory Responses and Glycometabolism Pathways: A Review
Previous Article in Special Issue
Changes in Macronutrients during Dieting Lead to Weight Cycling and Metabolic Complications in Mouse Model
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Effects of Anthocyanins on Components of Metabolic Syndrome—A Review

by
Michaela Godyla-Jabłoński
1,
Ewa Raczkowska
1,*,
Anna Jodkowska
2,
Alicja Zofia Kucharska
3,
Tomasz Sozański
4 and
Monika Bronkowska
5
1
Department of Human Nutrition, Faculty of Biotechnology and Food Science, Wrocław University of Environmental and Life Sciences, Chełmońskiego 37, 51-630 Wrocław, Poland
2
Department of Internal Medicine, Occupational Diseases, Hypertension and Clinical Oncology, Wrocław Medical University, Borowska 213, 50-556 Wrocław, Poland
3
Department of Fruit, Vegetable and Plant Nutraceutical Technology, Wrocław University of Environmental and Life Sciences, Chełmońskiego 37, 51-630 Wrocław, Poland
4
Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Wrocław University of Science and Technology, Wybrzeże Wyspiańskiego 27, 50-370 Wrocław, Poland
5
Institute of Health Sciences—Collegium Salutis Humanae, University of Opole, Katowicka 68, 45-060 Opole, Poland
*
Author to whom correspondence should be addressed.
Nutrients 2024, 16(8), 1103; https://doi.org/10.3390/nu16081103
Submission received: 14 March 2024 / Revised: 4 April 2024 / Accepted: 7 April 2024 / Published: 9 April 2024

Abstract

:
Metabolic syndrome (MetS) is a significant health problem. The co-occurrence of obesity, carbohydrate metabolism disorders, hypertension and atherogenic dyslipidaemia is estimated to affect 20–30% of adults worldwide. Researchers are seeking solutions to prevent and treat the conditions related to MetS. Preventive medicine, which focuses on modifiable cardiovascular risk factors, including diet, plays a special role. A diet rich in fruits and vegetables has documented health benefits, mainly due to the polyphenolic compounds it contains. Anthocyanins represent a major group of polyphenols; they exhibit anti-atherosclerotic, antihypertensive, antithrombotic, anti-inflammatory and anticancer activities, as well as beneficial effects on endothelial function and oxidative stress. This review presents recent reports on the mechanisms involved in the protective effects of anthocyanins on the body, especially among people with MetS. It includes epidemiological data, in vivo and in vitro preclinical studies and clinical observational studies. Anthocyanins are effective, widely available compounds that can be used in both the prevention and treatment of MetS and its complications. Increased consumption of anthocyanin-rich foods may contribute to the maintenance of normal body weight and modulation of the lipid profile in adults. However, further investigation is needed to confirm the beneficial effects of anthocyanins on serum glucose levels, improvement in insulin sensitivity and reduction in systolic and diastolic blood pressure.

1. Introduction

According to recent data [1,2,3], there has been an epidemic increase in the incidence of non-communicable chronic diseases, which include type 2 diabetes mellitus, cardiovascular diseases, chronic respiratory diseases and cancer. They now represent the leading causes of death and disability throughout the world. With the increasing consumption of energy-dense and nutrient-poor foods, non-communicable chronic diseases, including metabolic syndrome (MetS), have become a global problem and contribute significantly to rising healthcare costs [4,5,6].
MetS refers to the co-occurrence of disorders that, when present together in the human body, increase the risk of atherosclerosis and cardiovascular disease (Figure 1). MetS-related factors include visceral obesity, dyslipidaemia (a low high-density lipoprotein cholesterol [HDLc] fraction of <40 mg/dL in men and <50 mg/dL in women, along with a triglyceride [TG] level of ≥150 mg/dL) and hypertension (systolic blood pressure [SBP] ≥ 130 mmHG and diastolic blood pressure [DBP] ≥ 85 mmHg) [7,8]. The prevalence of MetS varies from 24.0% to 69.3% among demographic and population groups [9,10].
In their systematic review and meta-analysis, Noubiap et al. [11] found that the global incidence of MetS ranged from 12.5% to 31.4%. The authors also noted a significantly higher incidence of MetS in the Americas and the Eastern Mediterranean; it correlated positively with higher country income levels. In a meta-analysis of 45,811 patients with type 1 diabetes mellitus, 23.7% of the patients had been diagnosed with MetS. The highest prevalence of MetS was observed among Australians (27.3%) and the lowest among Africans (13.1%). The incidence of MetS was slightly higher in women (25.9%) compared with men (22.5%) [12]. The incidence of MetS in Europe varies according to the country and the definition used. The lowest incidence has been reported in the United Kingdom (3.0%) and the highest in Finland (71.7%) [13]. The National Health and Nutrition Examination Survey (NHANES) 2011–2018, which involved 8183 non-pregnant women aged ≥ 20 years, led to different results. The overall prevalence of MetS increased from 37.6% in 2011 to 41.8% in 2017, mainly in participants with a low education level [14]. In addition, the prevalence of MetS has been shown to increase with age, with a 5-fold increase in women and a 2-fold increase in men [15]. Studies involving Asian populations have reported a MetS incidence of 31.0–52.8% [16,17]. In the United States, there has also been an increasing trend over the past few decades, with variations at different times. Between 1999 and 2014, the overall prevalence of MetS increased by 4.7% (from 27.6% to 32.3%) [18]. Another study conducted between 2011 and 2018 showed an increase in the prevalence of MetS from 37.6% to 41.8%. However, the initial study covering the period of 2011–2018 showed that the incidence of MetS had remained stable over this period [14]. It should be noted that the cited studies have different timeframes and cover different population groups of varying sizes, which contributes to the differences in the results obtained.
The main factors contributing to the spread of this disease are an increase in the consumption of products with a high energy density and low nutritional value and low or no physical activity. These foods are high in saturated fatty acids and simple carbohydrates and low in complete protein, polyunsaturated fatty acids, dietary fibre, vitamins, minerals and other biologically active compounds [4,5].
Figure 1. The causes and consequences of metabolic syndrome [19,20,21].
Figure 1. The causes and consequences of metabolic syndrome [19,20,21].
Nutrients 16 01103 g001

2. Criteria for the Diagnosis of MetS

The first organisation to adopt and disseminate the term ‘metabolic syndrome’ was the World Health Organization (WHO) in 1998. At that time, the WHO experts identified impaired carbohydrate metabolism, in particular decreased insulin sensitivity of target tissues, as the main criterion for the diagnosis of MetS. Additional guidelines for the diagnosis of MetS were the presence of at least two of four distinguished disorders, namely visceral obesity, dyslipidaemia, elevated BP or excretion of small amounts of protein (microalbuminuria) in the urine [22]. In 2022, several Polish societies published a position paper on the definition of MetS and practical management of patients with this condition [23]. The authors considered the presence of android obesity (waist circumference ≥ 88 cm in women and ≥102 cm in men) or body mass index (BMI) ≥ 30 kg/m2 and two of the three components shown in Table 1 as criteria for the diagnosis of MetS.
Overweight and obesity, especially excessive visceral fat accumulation, are major risk factors for the development of insulin resistance, type 2 diabetes mellitus, non-alcoholic steatohepatitis, ischaemic heart disease, stroke and certain types of cancer [4,5]. Researchers have shown that inappropriate diets in children and adolescents intensify the risk of diet-related diseases, including MetS, in adulthood [24,25,26,27]. There are different methods for diagnosing MetS in children and adolescents. According to the International Diabetes Federation (IDF) criteria, among children aged 10–16 years, MetS is diagnosed if there is central obesity (≥90 centile) and two of the following factors: fasting glucose ≥ 100 mg/dL or previously diagnosed type 2 diabetes mellitus, SBP ≥ 130 mmHg or DBP ≥ 85 mmHg, serum TG ≥ 150 mg/dL and high-density lipoprotein cholesterol (HDLc) < 40 mg/dL. Piotrowska et al. [28] showed that at least one component of MetS was found in approximately 15.0% of 771 students aged 10–18 years. In the study group, the most common MetS components were excessive WC, reduced HDLc, elevated serum TG and elevated BP.
An important factor that may have increased the risk of MetS in adulthood is the coronavirus disease 2019 (COVID-19) pandemic, which has caused, among other things, a change in the lifestyle of children and adolescents. This was demonstrated in a study carried out in Italy involving 965 parents and their children aged 5–18 years [29]. The authors reported an increase in the total amount of food consumed (by 50.0%), an increased intake of high-energy snacks, a decrease in physical activity and, at the same time, an increase in body weight.
Overweight and obesity during childhood and adolescence carry a number of possible risks to a person’s health and even life. They lead to numerous complications that manifest in adolescence and adulthood. Excess body fat accumulation increases the likelihood of the onset of MetS in early childhood with all of its consequences—that is, abdominal obesity, type 2 diabetes mellitus, hypertension and/or dyslipidaemia. In adults, on the other hand, it mainly increases the risk of cardiovascular disease and obesity [30,31,32].
The components of MetS have also been identified as risk factors for the development of viral infection due to their effect on the body’s immune response. This has been noted in numerous observations related to COVID-19. Indeed, there is a close association between the presence of obesity, hypertension, diabetes mellitus and cardiovascular disease and a more severe course and increased mortality among patients infected with COVID-19 [33,34,35,36].
In recent years, a great deal of research has been devoted to issues related to the prevention and effective management of MetS and non-communicable chronic diseases. Non-pharmacological management—that is, dietary changes and increased physical activity—have been shown to be the basis for the prevention and treatment of these diseases [37,38,39]. One of the documented ways to influence the prevention of MetS is the introduction of anthocyanin-rich foods; they provide numerous benefits, including the ability to counteract the development of obesity and to improve adipocyte function [40,41,42]. Epidemiological studies and nutritional interventions have demonstrated a broad spectrum of biological effects that may benefit patients with MetS-related chronic diseases [43,44].

3. The Occurrence and Content of Anthocyanins in Fruits and Vegetables and Their Processed Products

Anthocyanins are the largest group of water-soluble pigments belonging to the flavonoid group. They are usually responsible for the red, blue and purple colour of fruits and vegetables [45,46]. Fresh raspberry (2199.0 mg/100 g) [47], cranberry (835.2 mg/100 g) [48] and chokeberry (686.0 mg/100 g) [49] have the highest total anthocyanin contents. Other studies have indicated the following contents in whole fruit: a maximum of 22.1 mg/100 g in fresh red currants [50]; approximately 465.4 mg anthocyanins/100 g (as cyanidin-3-glucoside equivalents) in blackberries [51]; 204.3 mg anthocyanins/100 g in strawberries [52]; 287.8 mg/100 g in blackcurrants [50]; 344.9 mg/100 g in cherries [53]; and 534.2 mg/100 g in blueberries [54]. The fruit extracts with the highest anthocyanin contents include chokeberry (up to 9360.0 mg/100 g) [55], blueberry (up to about 1301.2 mg/100 g) [56] and cranberry (520.0 mg/100 g) [57]. Among vegetables, fresh red cabbage has the highest reported anthocyanin content (275.4 mg/100 g) [58]; its extracts also have the highest anthocyanin content (up to 191.4 mg/100 g) [59]. Some studies used purified extracts, such as the studies by Bushmelev et al. [55] or Roda-Serrat et al. [60], and therefore the extracts of these fruits are characterised by a higher anthocyanin content compared to fresh or frozen fruit, where the anthocyanin content of non-purified extracts is determined.
Table 2 shows the anthocyanin contents of selected fruits, vegetables and their processed products. The anthocyanin content of individual fruits and vegetables varies depending on the genotype, cultivar, growing region, weather conditions during plant growth and ripening, maturity stage at harvest, storage method of the raw material, extraction methods used, precision of the analytical methods used and the form of fruit and vegetable that was analysed [61,62,63,64,65,66]. In addition, the anthocyanin content can be expressed as total anthocyanins determined with a spectrophotometric method or as cyanidin or delphinidin derivatives determined by high-performance liquid chromatography (HPLC). Due to the large discrepancies in the results obtained by different authors, it is often difficult to compare the content of these compounds in the same raw material. The lower content of total anthocyanins in fruit products (e.g., juices) compared with fresh raw material may be due to changes in the chemical composition, pH, temperature and exposure to oxygen and light during fruit processing [67,68]. Therefore, when comparing the anthocyanin content of individual fruits and vegetables, it is important to consider the many factors that affect the final concentrations of these pigments.

4. Structure of Anthocyanins

The common feature of all anthocyanins is a carbon skeleton consisting of two aromatic rings linked by a three-carbon chain. There are differences among anthocyanins regarding the number of hydroxyl groups, their degree of methylation and the type and number of sugars and their site of attachment to the aglycone. The most common anthocyanin is cyanidin 3-O-glucoside. Anthocyanins are most commonly glycosylated with glucose in the C-3 position, but this sugar can also be rhamnose, xylose, galactose or arabinose. Many di- and trisaccharides occur in various combinations with the previously mentioned sugars. In addition to the C-3 position, other sugars can also be attached to any of the hydroxyls at the C-3′, C-5, C-5′, C-7 and even C-4′ positions. Sugars can be esterified with aromatic or aliphatic acids to produce mono- and polyacylated anthocyanins. The acids attached to the sugars in the anthocyanin molecule are usually compounds from the hydroxycinnamic acid group (ferulic, caffeic, p-coumaric or sinapinic acid). Such compounds are found most often in vegetables [45,46].
The chemical structure of individual anthocyanins influences their biological activity. Koss-Mikołajczyk et al. [127] showed that the number and position of methoxy and hydroxyl groups in the structure of anthocyanidins are strongly related to their antioxidant and biological activity. There was higher antioxidant activity in compounds containing more hydroxyl groups in the B ring (pelargonidin < cyanidin < delphinidin). By substituting a methoxy group in place of the hydroxyl group, there was a decrease in the antioxidant activity (malvidin < petunidin < delphinidin, peonidin < cyanidin). It has been established that for the antioxidant capacity of anthocyanins, the 3′ and 4′ hydroxyl groups in their structure, which can be easily oxidised by donating one or two electrons, play a key role [127]. The results of several studies have already indicated that delphinidin has the strongest antioxidant activity among the anthocyanidins and the high antioxidant activity of petunidin and cyanidin due to the hydroxyl groups at the 3′ and 4′ positions [128,129].
Malvidin, pelargonidin and peonidin show lower reducing power because they have a single hydroxyl group in the B ring [130]. The chemical structure of some mono- or di-glycosylated anthocyanins is shown in Figure 2. In addition, the natural acylation of anthocyanins leads to more stable compounds with more beneficial biological effects compared with their non-acylated analogues [131]. Fei et al. [132] demonstrated that four acylated anthocyanins with maleic anhydride derived from blueberries via a solid-phase grafting method showed better stability than their native non-acylated forms, regardless of the degree of acylation. Their antioxidant potential, however, was somewhat lower, as they were less effective at capturing 2,2-diphenyl-1-picrylhydrazyl (DPPH) radicals. In turn, the methylation of anthocyanins plays a role in their water solubility and structural stability [133,134]. Glycosylation also improves the structural stability of anthocyanins, but it also reduces their bioactivity [135].

5. The Effects of Anthocyanins on the Prevention and Supportive Treatment of the Components of MetS

5.1. In Vitro Studies

Numerous in vitro studies have demonstrated the positive effects of anthocyanins contained in fruit extracts on the components of MetS (Table 3), including type 2 diabetes mellitus. Indeed, they have been found to inhibit carbohydrate digestive enzymes (especially α-glucosidase), to facilitate glucose transporter 4 (GLUT4) translocation, to increase glucagon-like peptide-1 (GLP-1) secretion and to interact with sodium–glucose cotransporter (SGLT) to delay glucose absorption in various organs and tissues [136,137,138]. Anthocyanins have also been shown to improve cellular glucose uptake and to enhance tissue insulin sensitivity [139,140,141].
Fruits are an excellent source of anthocyanins with anti-inflammatory properties, which may hold promise in the development of nutraceuticals for the prevention and treatment of chronic inflammation associated with MetS [142]. A study conducted on human umbilical vein endothelial cells (HUVECs) demonstrated the anti-inflammatory properties of malvidin-3-glucoside and malvidin-3-galactoside contained in blueberries. They affected monocyte chemotactic protein-1 (MCP-1), which regulated monocyte/macrophage migration and infiltration, and intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) [143]. Warner et al. [144] presented similar results: anthocyanin metabolites (cyanidin-3-O-glucoside) reduced VCAM-1 and interleukin-6 (IL-6) production. Anthocyanins may also have a positive effect on lipid metabolism by reducing cholesterol absorption. This action involves the inhibition of pancreatic lipase, reduction in micellar cholesterol solubility and inhibition of cholesterol uptake [145,146,147]. Further investigation is needed to fully understand the effects of anthocyanins on MetS components in vitro and to determine their potential as dietary supplements or the basis for novel medications.
Table 3. The effects of anthocyanins on the components of metabolic syndrome (in vitro studies).
Table 3. The effects of anthocyanins on the components of metabolic syndrome (in vitro studies).
Ref.Laboratory ModelPropertiesFood or CompoundEffects
[148]B16-F10 metastatic melanoma murine cellsAntitumour effectBlueberryInhibition of B16-F10 proliferation (at concentrations of >500 μg/mL);
stimulation of apoptosis;
↑ total LDH activity
[145]Caco-2 cellsHypocholesterolaemic effectBlack rice↓ Cholesterol uptake
[143]HUVECsAnti-inflammatory effectBlueberry↓ MCP-1, ICAM-1 and VCAM-1 production
[139]3T3-L1 adipocytesAntidiabetic effectPurple corn pericarp and pure anthocyanins↑ Glucose uptake;
activation of insulin signalling
[149]HepG2 cells (a human liver cancer cell line)Antidiabetic effectMulberry↑ Glucose consumption, glycogen content and PEPCK and G6Pase activities;
↓ glucose production
[140]3T3-L1 adipocytesRegulation of glucose metabolismCyanidin-3-
rutinoside
↑ Glucose uptake
[137]Jejunum samples from RF/J mice; HT-29, Caco-2 and NCM460 cells (human intestinal cell lines)Antidiabetic effectDelphinidinInhibition of glucose absorption
[144]HUVECsAnti-inflammatory effect13C5-cyanidin-3-
glucoside
↓ VCAM-1 and IL-6 production
[147]Caco-2 cellsHypolipidaemic effectCyanidin-3-
rutinoside
Inhibition of pancreatic cholesterol esterase and the formation of cholesterol micelles;
↓ cholesterol uptake
[146]Caco-2 cellsHypolipidaemic effectThai berriesInhibition of pancreatic lipase and cholesterol esterase;
bind to primary and secondary bile acids;
↓ cholesterol uptake
[150]Osteoblast cultureAnti-osteoporotic effectRed and yellow
Cornus mas L. fruit
↓ TRAP activity and the number of TRAP-positive multinucleated cells
[138]HepG2 cellsAntidiabetic effectBlueberryInhibition of α-glucosidase
Abbreviations: G6Pase, glucose-6-phosphatase; HUVECs, human umbilical vein endothelial cells; ICAM-1, intercellular adhesion molecule 1; IL-6, interleukin-6; LDH, lactate dehydrogenase; MCP-1, monocyte chemotactic protein-1; PEPCK, phosphoenolpyruvate carboxykinase; TRAP, tartrate-resistant acid phosphatase; VCAM-1, vascular cell adhesion molecule 1; ↓, lowering the concentration; ↑, increase the concentration.

5.2. In Vivo Studies with Animal Models

Numerous in vivo studies with animal models have demonstrated the health-promoting effects of anthocyanins contained in fruits and vegetables, including benefits regarding carbohydrate and lipid metabolism and anti-inflammatory, hypotensive and weight-reducing effects. Table 4 presents the effects of anthocyanins on components of MetS based on in vivo studies in animal models. The findings suggest that the effects of anthocyanins may vary depending on the dose used, the duration of the experiment, individual differences in the absorption and metabolism of biologically active compounds and the presence of other substances.

5.2.1. Effects on Carbohydrate Metabolism

Several in vivo studies have shown beneficial effects of anthocyanins on carbohydrate metabolism. These compounds may ameliorate type 2 diabetes mellitus by controlling postprandial hyperglycaemia via the inhibition of α-amylase and α-glucosidase [184], which are primary risk factors for the development of MetS. Dzydzan et al. [171] showed that anthocyanins in cornelian cherries (Cornus mas L.) may contribute to the alleviation of hyperglycaemia. In addition, these compounds exhibited antidiabetic and antioxidant effects by inhibiting oxidative processes involving protein and lipid modification, advanced glycation and the formation or accumulation of oxidative proteins. Furthermore, the authors observed lower blood glucose levels and a reduction in excessive thirst (polydipsia), which is one of the primary symptoms of type 1 and type 2 diabetes mellitus [170]. These compounds also contribute to the stimulation of glucagon-like peptide-1 (GLP-1) secretion and to the inhibition of dipeptidyl peptidase IV (DPP-IV) [177]. In addition, anthocyanins reduce the production of reactive oxygen species (ROS), prevent endoplasmic reticulum stress and inhibit pancreatic lipase activity, resulting in improved glycaemic control and lipidaemia and protecting the liver from insulin resistance induced by a high-fat diet [158,185]. The administration of red cabbage extract to rats with streptozotocin-induced type 1 diabetes mellitus resulted in lower serum glucose, glycated haemoglobin and foetal haemoglobin levels; improved glucose tolerance; and significantly increased serum insulin, proinsulin and C-peptide levels. At the same time, the addition of the extract improved pancreatic islet morphology by increasing the number of pancreatic β-cells [167].

5.2.2. Effects on Lipid Metabolism

In vivo studies have shown that anthocyanins have positive effects on lipid metabolism. These compounds in Aronia melanocarpa reduced the lipid content and inflammation in 3T3-L1 adipocytes and improved the blood lipid profile and degeneration of adipose tissue cells in mice fed a high-fat diet [186]. Blue honeysuckle anthocyanins had a normalising effect on plasma TG levels and lipid atherogenicity [155]. Cornelian cherry anthocyanins counteracted elevated TG levels and atherosclerotic changes in the thoracic aorta [159]. Black chokeberry anthocyanins promoted a 16.5% reduction in total cholesterol and the proatherogenic fraction of LDLc [160]. Raspberry anthocyanins normalised the serum lipid profile [169]. Black rice anthocyanin supplementation reduced TG, total cholesterol and insulin resistance in mice with obesity induced by a high-fat diet [174]. Blueberry anthocyanin extract and malvidin alleviated oxidative stress in the liver, inhibited hyperlipidaemia and improved lipid metabolism in mice with diabetes [177]. Blackcurrant anthocyanin supplementation alleviated hyperlipidaemia and hepatic steatosis and regulated hepatic lipid metabolism [175]. Zhang et al. [168] showed that anthocyanin extracts from lingonberry (Vaccinium vitis-idaea L.) regulated serum cholesterol metabolism and reduced inflammatory cell infiltration and fat deposition in liver cells.

5.2.3. Anti-Inflammatory Effects

Anthocyanins also exert anti-inflammatory effects. Gao et al. [187] showed that anthocyanins from purple vegetables—purple cabbage, purple sweet potato, purple corn and Gynura bicolor—effectively inhibited the production of pro-inflammatory factors such as nitric oxide (NO) and tumour necrosis factor alpha (TNF-α) [187]. Anthocyanins have also been shown to counteract the progression of obesity and osteoarthritis [188]. Ngamsamer et al. [189] highlighted the ability of anthocyanins to reduce markers of obesity-induced inflammation. Sozański et al. [159] added cornelian cherries to the diet of hypercholesterolaemic rats and reported a significant protective effect on diet-induced oxidative stress in the liver and a reduction in elevated serum pro-inflammatory cytokine levels. In addition, supplementing the diet of rabbits fed 1% cholesterol with loganic acid contributed to a reduction in TNF-α and IL-6, indicating an anti-inflammatory effect [162]. Other authors have reported that anthocyanins reduce C-reactive protein levels [156] and increase glutathione peroxidase (GSH-PX) and superoxide dismutase (SOD) activities in the liver [164,169]. In a model of obesity induced by an unbalanced diet, anthocyanins alleviated inflammation and oxidative stress, denoted by elevated GSH-PX and SOD activities in the liver and reduced TNF-α and IL-6 gene expression [163].

5.2.4. Antioxidant Properties

There are findings in the literature supporting the antioxidant properties of anthocyanins, which play a central role in minimising the symptoms of MetS. A study conducted by Wang et al. (2014) compared the total antioxidant capacity (T-AOC) of two sources of anthocyanins, pomegranate peel extract and black bean peel extract, on oxidative stress-induced hyperglycaemia in streptozotocin-induced diabetic mice. Black bean peel extract had a slightly higher antioxidant capacity (13 U/mL T-AOC) compared to pomegranate peel extract (10 U/mL T-AOC) [180]. Anthocyanins, especially from blueberries, have shown significant antioxidant properties in animal studies. Blueberry anthocyanins have shown concentration-dependent antioxidant effects in mice, increasing total antioxidant capacity and reducing oxidative stress markers such as malondialdehyde [181]. In Wistar rats, the administration of anthocyanins led to a dose-dependent improvement in the activity of serum antioxidant enzymes such as catalase, superoxide dismutase and glutathione peroxidase [182]. Furthermore, the nano-encapsulation of anthocyanins increased their stability and bioavailability in various tissues, improving protection against oxidative damage in in vivo studies [190]. In another study in guinea pigs fed a high-cholesterol diet fortified with an 8% addition of fresh blueberries for 75 days, a reduction in oxidative stress was observed by reducing malondialdehyde concentrations [183]. The above studies indicate that anthocyanins, especially those with intense pigmentation, can be used to overcome oxidative stress damage. Although most food sources contain varying levels of these compounds, it is important to consider how the food source may affect their antioxidant capacity [191,192].

5.2.5. Influence on Body Weight

A number of studies have confirmed the beneficial effects of anthocyanins on weight and BMI reduction [193]. Specifically, anthocyanin supplementation at ≤300 mg/day for 4 weeks has been shown to effectively reduce BMI and body weight [194]. Additionally, anthocyanins contained in Lycium ruthenicum Murray fruit counteracted obesity by inhibiting pancreatic lipase and regulating the intestinal microflora [176]. Furthermore, anthocyanin extracts from L. ruthenicum as well as blueberries and cranberries reduced weight gain and total body fat mass [166,176]. Mulberry aqueous extracts added to the diet (0.5–2.0%, w/w) counteracted obesity induced by a high-fat diet (0.2% cholesterol and 10% corn oil) in a hamster model of obesity [153]. Mulberry extract reduced body weight and visceral fat mass and exerted a hypolipidaemic effect. Both mulberry leaf and fruit extracts have been reported to reduce body weight and visceral fat [153,154]. Similar effects have also been observed with the administration of 100–200 mg/kg body weight anthocyanins from honeysuckle [157]; 200 mg/kg body weight anthocyanins from mulberries (by 32.7%) or cherries (by 29.6%) [163]; 200 mg/kg body weight anthocyanins from purple corn, black soybean or black rice [164]; 200 mg/kg body weight anthocyanins from raspberries [169]; and 100–300 mg/kg body weight anthocyanins from blackcurrants [161,175].

5.2.6. Effects on BP

There are relatively few published animal studies that have determined the effects of anthocyanins on blood pressure (BP). Xu et al. [179] showed that chronic infusion of anthocyanins into the paraventricular nucleus of rats with salt-induced hypertension reduced BP and peripheral sympathetic nerve activity. Anthocyanins from Hibiscus sabdariffa reduced salt-induced hypertension in rats by inhibiting components of the renin–angiotensin–aldosterone system [178]. Yamane et al. [165] reported that supplementing a standard diet with 10% freeze-dried chokeberries reduced BP in spontaneously hypertensive rats. In addition, the administration of anthocyanin-rich pigments from purple maize, purple sweet potatoes and red radishes to spontaneously hypertensive rats reduced BP and heart rate, but not body weight, compared with rats that did not receive supplementation [151]. Herawati et al. [172] reported that 50 and 100 mg/kg body weight anthocyanins from purple sweet potatoes reduced SBP (to 116.67 ± 2.80 mmHg and 106.50 ± 1.87 mmHg, respectively).

5.3. In Vivo Studies with Humans

The increasing prevalence of obesity, type 2 diabetes mellitus, cardiovascular diseases and cancer has prompted a search for naturally occurring compounds in fruits, vegetables and herbs that, when included in appropriate amounts in the diet and without altering physical activity and lifestyle, could reduce the risk of particular diseases. Table 5 presents the effects of anthocyanins on components of MetS based on in vivo studies that involved humans.

5.3.1. Effects on Carbohydrate Metabolism

Numerous in vivo studies involving humans have demonstrated the positive effects of anthocyanins on carbohydrate metabolism. Among other actions, anthocyanins can inhibit carbohydrate-digesting enzymes. Indeed, blue honeysuckle extract inhibited the activity of α-amylase and α-glucosidase [220]. The inhibition of carbohydrate digestive enzymes can facilitate GLUT4 translocation, suppress the efficiency of DPP-IV and prevent protein tyrosine phosphatase 1B (PTP1B) overexpression [221]. A study confirmed the beneficial effects of anthocyanins on carbohydrate metabolism in people with MetS [214]. After 4 weeks of anthocyanin supplementation (320 mg twice a day), there was a 13.3% reduction in fasting serum glucose levels in the MetS group. This supplementation also improved tissue insulin sensitivity [214]. Nolan et al. [213] reported that ad hoc and short-term supplementation with New Zealand blackcurrant extract improved insulin sensitivity and reduced postprandial glucose concentrations. Solverson et al. [222] found that mixed berry preparations (consisting of blackberries, blueberries, cranberries, raspberries and strawberries) reduced the serum insulin response. Novotny et al. [202] reported the beneficial effects of anthocyanins, proanthocyanidins and total phenols contained in low-calorie cranberry juice on glucose levels and insulin resistance [202]. During a 6-week intervention with the addition of 150 g of frozen bilberries three times per week, there was a reduction in serum glucose concentrations. There was a significant improvement in tissue insulin sensitivity (by 14%) in a group of individuals with overweight or obesity (BMI ≥ 25.0 kg/m2) and insulin resistance who consumed a drink containing 333 mg of strawberry and cranberry polyphenols each day [207]. During a 1-week dietary intervention with a strictly anthocyanin-free ration except for the addition of blackberry among 27 men with overweight or obesity (BMI > 25 kg/m2), there was a significant increase in tissue insulin sensitivity. There was a significant reduction in homeostatic model assessment for insulin resistance (HOMA-IR) scores and a significant increase in the area under the curve (AUC) for non-esterified fatty acids (NEFAs) in the study group [209]. In addition, anthocyanins in black rice extract and β-glucan from oats influenced the inhibition of starch-digesting enzymes and lowered the glycaemic index of cooked white rice [223]. In contrast, Kolehmainen et al. [224] did not observe a beneficial effect of the addition of bioactive compounds on lowering serum glucose. This may be due to methodological differences between the studies and the different sizes of the study groups.

5.3.2. Effects on Lipid Metabolism

Fruit and vegetable anthocyanins can modulate TG, total cholesterol, LDLc and HDLc levels to improve the lipid profile. The effect on lipid metabolism depends on the type of anthocyanin. In one study, delphinidin-based anthocyanins, but not cyanidin- and malvidin-based anthocyanins, significantly affected TG, LDLc and HDLc levels [225]. Asgara et al. [197] introduced 50 g of cornelian cherries twice a day to the diet of 9–16-year-old children and reported a reduction in total cholesterol and LDLc and TG levels and an increase in HDLc levels compared with the baseline [197]. Habanova et al. [211] showed that the regular consumption of juice containing 50% berries (25% chokeberry, 15% blueberry and 10% cranberry) and 50% apple juice could become an important strategy to reduce the risk of developing cardiovascular disease by modulating the lipid profile (a significant increase in HDLc and a reduction in total cholesterol). Only the male subjects showed a significant reduction in total cholesterol and LDLc levels [211]. Another study showed an effect of 25 or 50 g of freeze-dried strawberries only on total cholesterol and LDLc levels among people with abdominal obesity and elevated serum lipids [199]. The same effects were observed in a group of women with overweight or obesity who were given 500 mL of commercial orange juice containing approximately 250 mg of anthocyanins each day for 12 weeks [206]. Overall, several studies have reported an increase in HDLc levels and a decrease in TG, total cholesterol and LDLc levels [200,202,204,205,208,214]. In addition, there was a reduction in albumin and a transferase involved in drug and xenobiotic detoxification (γ-glutamyltransferase) with regular consumption of 150 g of frozen bilberries (Vaccinium myrtillus L.) three times per week. Wright et al. [198] administered dried purple carrot providing 118.5 mg of anthocyanins and 259.2 mg of phenolic acids each day to men with obesity for 4 weeks. These anthocyanins and phenolic acids did not significantly reduce total cholesterol and LDLc levels. Moreover, they exerted an undesirable effect by lowering HDLc levels [198]. Several studies have reported the lack of a positive effect of anthocyanins on the blood lipid profile [207,212,224].
The administration of 100 mL/day of chokeberry juice (containing 1177.11 mg gallic acid equivalents) or a low dose of polyphenols (294. 28 mg gallic acid equivalents) altered plasma phospholipids fatty acids (PPFAs): there was an increase in saturated fatty acids (SFAs), especially palmitic acid (PA), and a decrease in n-6 polyunsaturated fatty acids (PUFAs), primarily linoleic acid (LA) [212]. In the human body, LA can undergo metabolic interconversion to long-chain n-3 PUFAs, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). PUFAs contribute to reducing oxidative stress by modulating inflammatory processes. They also reduce the risk of developing and the severity of cardiovascular diseases and are essential components in normal brain development and cognitive function [226]. An adequate PA concentration in tissues maintains the physical properties of membranes as well as the attachment of fatty acids to specific proteins, which contribute to the hydrophobicity of proteins and to their membrane association. However, a balance between the daily ration of PA and PUFAs is necessary to maintain the balance of membrane phospholipids. Modern lifestyles based on an excessive supply of energy and simple carbohydrates and low physical activity contribute to an imbalance in the PA concentration. Excessive PA accumulation in tissues may contribute to the development of dyslipidaemia or hyperglycaemia [227].

5.3.3. Anti-Inflammatory Effects

Similarly to animal models, anthocyanins exert anti-inflammatory effects in humans. According to Masheta et al. [217], anthocyanin extracts reduced oxidative stress and inflammation in people with hypertension and diabetes mellitus, confirming their potential to delay complications associated with these chronic diseases. In addition, blueberry, blackberry, cranberry and blackcurrant anthocyanins have been reported to inhibit inflammation in preadipocytes, which store low-grade inflammatory biomarkers associated with obesity [228]. Dietary anthocyanins have also been found to have beneficial effects on chronic inflammatory disorders such as intestinal diseases [188]. The antioxidant, anti-inflammatory and immunomodulatory properties of anthocyanins contribute to their anti-inflammatory effects [229]. Basu et al. [196] showed that the consumption of two cups of low-energy cranberry juice per day significantly reduced lipid oxidation and increased the plasma antioxidant capacity in a group of women with MetS. In the study group consuming 50 g of freeze-dried blueberries, there was a significant reduction in plasma oxidised LDL and oxidative stress markers (malondialdehyde and hydroxynonenal) compared with the control group [196]. Several studies have reported significant reductions in C-reactive protein levels with anthocyanin supplementation: with the equivalent of 400 g of fresh bilberries (40 g of dried bilberries, equivalent to 200 g of fresh bilberries, and 200 g of bilberry purée) [224], following the administration of 300 mL/day blackberry juice with pulp [204] and among women who received 320 mg of anthocyanins [214]. In addition, bilberry consumption reduced the pro-inflammatory cytokines IL-6 and IL-12 [224]. However, Paquette et al. [207] and Xie et al. [208] did not find that bioactive compounds altered markers of inflammation and oxidative stress. Anthocyanins and phenolic acids from purple carrots also did not significantly reduce C-reactive protein levels [198]. Moreover, in a group of 60 people with abdominal obesity and elevated serum lipids, a 12-week intervention with 25 or 50 g of freeze-dried strawberries did not reduce C-reactive protein levels [199].

5.3.4. Antioxidant Properties

Fruits and vegetables rich in anthocyanins show strong antioxidant properties. This is confirmed by studies with humans, indicating potential health benefits also in reducing the symptoms of metabolic syndrome. Due to their ability to potentially scavenge free radicals and reduce oxidative stress, the consumption of anthocyanins from a diet rich in fruit and vegetables has been linked to slowing the progression of oxidative damage [230]. Anthocyanins protect biological systems from free radical toxicity through various avenues and, as potent antioxidants, act as reducing factors in the electron transfer reaction pathway, transferring electrons to free radicals with unpaired electrons [231,232]. Anthocyanins interact with the NF-κB and AP-1 signal transduction pathways, which respond to oxidative signals, and with the Nrf2/ARE pathway and its regulated cytoprotective proteins (GST, NQO, HO-1), involved in cellular antioxidant defence as the elimination/inactivation of toxic compounds, thus counteracting oxidative stress-induced changes [218]. One study relying on the administration of 480 mL/day of cranberry juice to individuals with established MetS reported a significant increase in plasma antioxidant capacity (1.5 ± 0.6 to 2.2 ± 0.4 µmol/L) and a decrease in malondialdehyde concentration (3.4 ± 1.1 to 1.7 ± 0.7 µmol/L) [219]. Also, in a study by Kuntz et al. (2014), a reduction in malondialdehyde concentrations and an increase in total antioxidant activity as determined by the Trolox equivalent antioxidant capacity (TEAC) method was observed in plasma and urine after the consumption of 330 mL/day of anthocyanin-rich juice or smoothie [218].

5.3.5. Influence on Body Composition and Measurements

Researchers have also assessed the effects of anthocyanins on body weight in humans. Numerous studies have shown that interventions with anthocyanins reduced BMI and body fat percentage [193,194,233,234]. In particular, anthocyanin supplementation at a dose of ≤300 mg/day for 4 weeks effectively reduced BMI and body weight [194]. However, Tiwari et al. [235] analysed 21 clinical trials and 27 preclinical studies and found that with a daily anthocyanin intake of ≤300 mg for 4 weeks, BMI reductions were observed more frequently in adults without obesity. During a 24-year follow-up of 124,086 healthcare workers in the United States, an increased intake of anthocyanins mainly from blueberries and strawberries was inversely correlated with weight gain [236]. An 8-week intervention in subjects with a BMI > 23 kg/m2 or a WC > 90 cm for men or >85 cm for women with anthocyanin-rich black soybean testa extracts had a beneficial effect on reducing WC and hip circumference [205]. Different results were obtained after a 4-week nutritional intervention involving the addition of anthocyanins and phenolic acids from purple carrots: there was no significant reduction in body mass or improvement in body composition [198]. In a group of women with overweight or obesity, the addition of 500 mL of commercial orange juice to the diet has no significant effect on body weight [206]. Moreover, a dose equivalent to 400 g of fresh bilberries for 8 weeks did not result in a significant weight reduction in the intervention group [224].

5.3.6. Effects on BP

Anthocyanins are being investigated by researchers in terms of their potential effects on BP in humans, but the results of the studies are inconclusive. These compounds have been shown to have antihypertensive potential via the renin–angiotensin–aldosterone pathway based on molecular docking calculations. Anthocyanin-derived compounds such as delphinidin, petunidin, malvidin, cyanidin, peonidin and pelargonidin have potential as antihypertensive drugs [237]. Basu et al. [195] assessed the effects of anthocyanins on BP in a group of 48 individuals with obesity and MetS. They found that consuming two glasses of juice containing 50 g of freeze-dried blueberries per day could significantly reduce SBP and DBP [195]. Aghababaee et al. [200] also reported a significant decrease in SBP in the intervention group [200], while Novotny et al. [202] reported a significant decrease in DBP. In contrast, the results of other studies have demonstrated no significant effect of anthocyanins on BP regulation in humans [198,199,208,212,217,238,239].

6. Summary and Observations

The divergent results obtained by different research groups are most likely due to the use of different sources of anthocyanins; variations in doses, preparations and forms used in the experiments; the durations of the observations; and methodological differences [240,241,242]. In addition, anthocyanins are affected by gastrointestinal pH and ions, which impact the bioactivity and bioavailability of these polyphenolic compounds [243]. Compounds in food may act synergistically. More often than not, it is not possible to consider all of the nutrients contained in foods when conducting studies. Additionally, the use of extracts containing only anthocyanins may be more effective when assessing their effects on the human body [244]. Differences in the effects of anthocyanins on the human body may also be related to socio-cultural and ethnic characteristics, as well as the season and technical advances in the agri-food industry [240,245]. To our knowledge, there have been few studies conducted with large population groups to confirm the beneficial effects of anthocyanin intake. Most of the available research details pilot studies conducted mainly in small groups and in the short term (usually 8–12 weeks). There is a lack of studies determining the long-term impact of anthocyanin intake on the prevention of diet-related diseases, especially among children and adolescents. Additional research is needed on foods with functional properties and phytopharmaceuticals containing anthocyanins, with a focus on components with synergistic effects.

7. Conclusions

This review highlights the need for a deeper understanding of the mechanisms involved in the metabolism and bioavailability of anthocyanins found in food. It would also be worth exploring the impact of food-derived anthocyanins on MetS development. The current scientific evidence suggests that anthocyanins are an effective, widely available and inexpensive way to prevent and treat MetS and its complications. An increase in the consumption of anthocyanin-rich foods may contribute to the maintenance of normal body weight and modulation of the lipid profile in adults. This knowledge may contribute to revisions in dietary recommendations against obesity and cardiovascular diseases and their possible consequences. The role of anthocyanins in the global food chain should be understood and considered when making dietary choices. Hopefully, the present review will contribute to revising dietary recommendations to reduce the prevalence of MetS while improving the health and quality of life of individuals with MetS.

Author Contributions

Conceptualisation, M.G.-J., M.B. and T.S.; writing—original draft preparation, M.G.-J. and E.R.; writing—review and editing, M.G.-J. and E.R.; visualisation, M.G.-J. and E.R.; supervision, M.B., A.Z.K., A.J. and T.S. All authors have read and agreed to the published version of the manuscript.

Funding

The APC is co-financed by the Wrocław University of Environmental and Life Sciences.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Gong, J.B.; Yu, X.W.; Yi, X.R.; Wang, C.H.; Tuo, X.P. Epidemiology of chronic noncommunicable diseases and evaluation of life quality in elderly. Aging Med. 2018, 1, 64–66. [Google Scholar] [CrossRef] [PubMed]
  2. He, X.; Shi, X.; Pan, D.; Wang, H.; Zhang, X.; Pu, L.; Luo, M.; Li, J. Secular trend of non-communicable chronic disease prevalence throughout the life span who endured Chinese Great Famine (1959–1961). BMC Public Health 2023, 23, 1238. [Google Scholar] [CrossRef] [PubMed]
  3. Peng, W.; Chen, S.; Chen, Y.; Ma, Y.; Wang, T.; Sun, X.; Wang, Y.; Ding, G.; Wang, Y. Trends in major non-communicable diseases and related risk factors in China 2002-2019: An analysis of nationally representative survey data. Lancet Reg. Health West. Pac. 2023, 43, 100809. [Google Scholar] [CrossRef] [PubMed]
  4. Lim, S. Targeting the pathophysiology and treatment of obesity and metabolic syndrome. J. Obes. Metab. Syndr. 2017, 26, 81–83. [Google Scholar] [CrossRef] [PubMed]
  5. Saklayen, M.G. The global epidemic of the metabolic syndrome. Curr. Hypert. Rep. 2018, 20, 12. [Google Scholar] [CrossRef]
  6. Wyszkowska, D.; Gabińska, M.; Romańska, S. Sytuacja Osób Starszych w Polsce w 2020 r; Główny Urząd Statystyczny: Warszawa, Poland; Białystok, Poland, 2020. [Google Scholar]
  7. Grund, S.M.; Brewer, H.B., Jr.; Cleeman, J.I.; Smith, S.C., Jr.; Lenfant, C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004, 109, 433–438. [Google Scholar] [CrossRef]
  8. Alberti, K.G.M.M.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; Loria, C.M.; Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [Google Scholar] [CrossRef] [PubMed]
  9. Mattsson, N.; Rönnemaa, T.; Juonala, M.; Viikari, J.S.A.; Raitakari, O.T. The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young FinnsStudy. J. Intern. Med. 2007, 261, 159–169. [Google Scholar] [CrossRef] [PubMed]
  10. AlShelleh, S.; AlAwwa, I.; Oweis, A.; AlRyalat, S.A.; Al-Essa, M.; Saeed, I.; Alhawari, H.H.; Alzoubi, K.H. Prevalence of metabolic syndrome in dialysis and transplant patients. Diabetes Metab. Syndr. Obes. 2019, 12, 575–579. [Google Scholar] [CrossRef] [PubMed]
  11. Noubiap, J.J.; Nansseu, J.R.; Lontchi-Yimagou, E.; Nkeck, J.R.; Nyaga, U.F.; Ngouo, A.T.; Tounouga, D.N.; Tianyi, F.L.; Foka, A.J.; Ndoadoumgue, A.L.; et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res. Clin. Pract. 2022, 188, 109924. [Google Scholar] [CrossRef] [PubMed]
  12. Belete, R.; Ataro, Z.; Abdu, A.; Sheleme, M. Global prevalence of metabolic syndrome among patients with type I diabetes mellitus: A systematic review and meta-analysis. Diabetol. Metab. Syndr. 2021, 13, 25. [Google Scholar] [CrossRef]
  13. Kwasny, C.; Manuwald, U.; Kugler, J.; Rothe, U. Systematic review of the epidemiology and natural history of the metabolic vascular syndrome and its coincidence with type 2 diabetes mellitus and cardiovascular diseases in different European countries. Horm. Metab. Res. 2018, 50, 201–208. [Google Scholar] [CrossRef] [PubMed]
  14. Liang, X.; Or, B.; Tsoi, M.F.; Cheung, C.L.; Cheung, B.M.Y. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad. Med. J. 2023, 99, 985–992. [Google Scholar] [CrossRef] [PubMed]
  15. Scuteri, A.; Laurent, S.; Cucca, F.; Cockcroft, J.; Guimaraes Cunha, P.; Mañas, L.R.; Mattace Raso, F.U.; Muiesan, M.L.; Ryliškytė, L.; Rietzschel, E.; et al. Metabolic syndrome across Europe: Different clusters of risk factors. Eur. J. Prevent. Cardiol. 2015, 22, 486–491. [Google Scholar] [CrossRef] [PubMed]
  16. Jayant, S.S.; Gupta, R.; Rastogi, A.; Sachdeva, N.; Ram, R.; Bhansali, D.A.; Bhadada, S.K. Incidence and predictors of metabolic syndrome in Asian-Indians: A 10-year population-based prospective cohort study. Int. J. Diabetes Dev. Ctries. 2023, 43, 916–922. [Google Scholar] [CrossRef] [PubMed]
  17. Bao, J.; Wang, L.; Hu, P.; Liu, J.; Tu, J.; Wang, J.; Li, J.; Ning, X. Burden of metabolic syndrome among a low-income population in China: A population-based cross-sectional study. Diabetes Metab. Syndr. Obes. 2022, 15, 2713–2723. [Google Scholar] [CrossRef] [PubMed]
  18. Li, W.; Qiu, X.; Ma, H.; Geng, Q. Incidence and long-term specific mortality trends of metabolic syndrome in the United States. Front. Endocrinol. 2023, 13, 1029736. [Google Scholar] [CrossRef] [PubMed]
  19. Dołowacka, A. Metabolic Syndrome as Another Disease of Affluence. Nurs. Public Health 2016, 6, 241–245. [Google Scholar] [CrossRef]
  20. Pinto, R.M.; Steinmetz, L.S.; Barbosa, J.M.G.; Mendes, A.F.C.S.; Curado, M.P.; da Cruz, A.D. The role of genetics in the pathophysiology of obesity: A systematic review. Obes. Res. Open J. 2019, 6, 11–17. [Google Scholar] [CrossRef]
  21. Bovolini, A.; Garcia, J.; Andrade, M.A.; Darte, J.A. Metabolic syndrome pathophysiology and predisposing factors. Int. J. Sports Med. 2021, 42, 199–214. [Google Scholar] [CrossRef] [PubMed]
  22. Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15, 539–553. [Google Scholar] [CrossRef]
  23. Dobrowolski, P.; Prejbisz, A.; Kuryłowicz, A.; Baska, A.; Burchardt, P.; Chlebus, K.; Dzida, G.; Jankowski, P.; Jaroszewicz, J.; Jaworski, P.; et al. Metabolic syndrome—A new definition and management guidelines. Arter. Hypertens. 2022, 26, 99–121. [Google Scholar] [CrossRef]
  24. Ilow, R.; Regulska-Ilow, B.; Płonka, K.; Biernat, J. Ocena sposobu żywienia gimnazjalistów w Oleśnicy. Rocz. Panstw. Zakl. Hig. 2008, 59, 335–341. [Google Scholar] [PubMed]
  25. Martins, V.J.B.; Toledo Florêncio, T.M.M.; Grillo, L.P.; Franco, M.C.P.; Martins, P.A.; Clemente, A.P.G.; Santos, C.D.L.; Vieira, M.F.A.; Sawaya, A.L. Long-lasting effects of undernrition. Int. J. Environ. Res. Public Health 2011, 8, 1817–1846. [Google Scholar] [CrossRef] [PubMed]
  26. Bhutta, Z.A.; Lassi, Z.S.; Bergeron, G.; Koletzko, B.; Salam, R.; Diaz, A.; McLean, M.; Black, R.E.; De-Regil, L.M.; Christian, P.; et al. Delivering an action agenda for nutrition interventions addressing adolescent girls and young women: Priorities for implementation and research. Ann. N. Y. Acad. Sci. 2017, 1393, 61–71. [Google Scholar] [CrossRef] [PubMed]
  27. Umer, A.; Kelley, G.A.; Cottrell, L.E.; Giacobbi, P., Jr.; Innes, K.E.; Lilly, C.L. Childhood obesity and adult cardiovascular disease risk factors: A systematic review with meta-analysis. BMC Public Health 2017, 17, 683. [Google Scholar] [CrossRef] [PubMed]
  28. Piotrowska, E.; Figurska-Ciura, D.; Łoźna, K.; Bienkiewicz, M.; Mazurek, D.; Wyka, J.; Węgiel, M.; Biernat, J.; Godyla-Jabłoński, M. Frequency of occurrence of metabolic syndrome risk factors in children and adolescents from the city of Wrocław and surroundings. Rocz. Panstw. Zakl. Hig. 2020, 71, 33–42. [Google Scholar] [CrossRef] [PubMed]
  29. Farello, G.; D’Andrea, M.; Quarta, A.; Grossi, A.; Pompili, D.; Altobelli, E.; Stagi, S.; Balsano, C. Children and adolescents dietary habits and lifestyle changes during COVID-19 lockdown in Italy. Nutrients 2022, 14, 2135. [Google Scholar] [CrossRef] [PubMed]
  30. Güngör, N.K. Overweight and obesity in children and adolescents. J. Clin. Res. Pediatr. Endocrinol. 2014, 6, 129–143. [Google Scholar] [CrossRef] [PubMed]
  31. Malczyk, E. Stan odżywienia dzieci i młodzieży w Polsce na podstawie piśmiennictwa z ostatnich 10 lat (2005–2015). Ann. Acad. Med. Siles 2016, 70, 56–65. [Google Scholar] [CrossRef]
  32. Kerns, J.; Fisher, M. Epidemiology, pathophysiology and etiology of obesity in children and adolescents. Curr. Probl. Pediatr. Adolesc. Health Care 2020, 50, 100869. [Google Scholar] [CrossRef] [PubMed]
  33. Klang, E.; Kassim, G.; Soffer, S.; Freeman, R.; Levin, M.A.; Reich, D.L. Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. Obesity 2020, 28, 1595–1599. [Google Scholar] [CrossRef] [PubMed]
  34. Petrilli, C.M.; Jones, S.A.; Yang, J.; Rajagopalan, H.; O’Donnell, L.F.; Chernyak, Y.; Tobin, K.A.; Cerfolio, R.J.; Francois, F.; Horwitz, L.I. Factors associated with hospitalization and critical illness among 4103 patients with COVID-19 disease in New York City. BMJ 2020, 369, m1966. [Google Scholar] [CrossRef] [PubMed]
  35. Singh, A.K.; Gupta, R.; Ghosh, A.; Misra, A. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab. Syndr. 2020, 14, 303–310. [Google Scholar] [CrossRef] [PubMed]
  36. Yang, Y.; Wang, L.; Liu, J.; Fu, S.; Zhou, L.; Wang, Y. Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19: A protocol for systematic review and meta-analysis. Medicine 2022, 101, e28499. [Google Scholar] [CrossRef] [PubMed]
  37. O’Keefe, J.H.; Cordain, L. Cardiovascular disease resulting from a diet and lifestyle at odds with our paleolithic genome: How to become a 21st-century hunter-gatherer. Mayo Clin. Proc. 2004, 79, 101–108. [Google Scholar] [CrossRef] [PubMed]
  38. Kapka-Skrzypczak, L.; Biliński, P.; Niedźwiecka, J.; Kulpa, P.; Skowron, J.; Wojtyła, A. Zmiana stylu życia człowieka jako metoda prewencji przewlekłych chorób niezakaźnych. Probl. Hig. Epodemiol. 2012, 93, 27–31. [Google Scholar]
  39. Egert, S.; Baxheinrich, A.; Lee-Barkey, Y.H.; Tschoepe, D.; Wahrburg, U.; Stratmann, B. Effects of an energy-restricted diet rich in plant-derived α-linolenic acid on systemic inflammation and endothelial function in overweight-to-obese patients with metabolic syndrome traits. Br. J. Nutr. 2014, 112, 1315–1322. [Google Scholar] [CrossRef] [PubMed]
  40. De la Iglesia, R.; Loria-Kohen, V.; Zulet, M.A.; Martinez, J.A.; Reglero, G.; Ramirez de Molina, A. Dietary strategies implicated in the prevention and treatment of metabolic syndrome. Int. J. Mol. Sci. 2016, 17, 1877. [Google Scholar] [CrossRef] [PubMed]
  41. Naseri, R.; Farzaei, F.; Haratipour, P.; Nabavi, S.F.; Habtemariam, S.; Farzaei, M.H.; Khodarahmi, R.; Tewari, D.; Momtaz, S. Anthocyanins in the management of metabolic syndrome: A pharmacological and biopharmaceutical review. Front. Pharmacol. 2018, 9, 1310. [Google Scholar] [CrossRef]
  42. Francini-Pesenti, F.; Spinella, P.; Calò, L.A. Potential role of phytochemicals in metabolic syndrome prevention and therapy. Diabetes Metab. Syndr. Obes. 2019, 12, 1987–2002. [Google Scholar] [CrossRef] [PubMed]
  43. Tsuda, T. Regulation of adipocyte function by anthocyanins; possibility of preventing the metabolic syndrome. J. Agric. Food Chem. 2008, 56, 642–646. [Google Scholar] [CrossRef] [PubMed]
  44. Jianga, X.; Lia, X.; Zhua, C.; Sunb, J.; Tiana, L.; Chenc, W.; Bai, W. The target cells of anthocyanins in metabolic syndrome. Crit. Rev. Food Sci. Nutr. 2019, 59, 921–946. [Google Scholar] [CrossRef] [PubMed]
  45. Takeoka, G.; Dao, L. Anthocyanins. In Methods of Analysis for Functional Foods and Nutraceuticals; Hurst, J., Ed.; CRC Press: Boca Raton, FL, USA, 2002; pp. 219–241. [Google Scholar]
  46. De Pascual-Teresa, S.; Sanchez-Ballesta, M.T. Anthocyanins: From plant to health. Phytochem. Rev. 2008, 7, 281–299. [Google Scholar] [CrossRef]
  47. Mazur, S.P.; Nes, A.; Wold, A.B.; Remberg, S.F.; Aaby, K. Quality and chemical composition of ten red raspberry (Rubus idaeus L.) genotypes during three harvest seasons. Food Chem. 2014, 160, 233–240. [Google Scholar] [CrossRef] [PubMed]
  48. Šedbarė, R.; Sprainaitytė, S.; Baublys, G.; Viskelis, J.; Janulis, V. Phytochemical composition of cranberry (Vaccinium oxycoccos L.) fruits growing in protected areas of Lithuania. Plants 2023, 12, 1974. [Google Scholar] [CrossRef] [PubMed]
  49. Kratchanova, M.; Petrova, I.; Klisurova, D.; Georgiev, Y.; Ognyanov, M.; Yanakieva, I. Black chokeberry (Aronia melanocarpa (Michx.) Elliot) fruits and functional drinks differ significantly in their chemical composition and antioxidant activity. J. Chem. 2018, 2018, 9574587. [Google Scholar] [CrossRef]
  50. Nour, V.; Trandafir, I.; Ionica, M.E. Ascorbic acid, anthocyanins, organic acids and mineral content of some black and red currant cultivars. Fruits 2011, 66, 353–362. [Google Scholar] [CrossRef]
  51. Kostecka-Gugała, A.; Ledwożyw-Smoleń, I.; Augustynowicz, J.; Wyżgolik, G.; Kruczek, M.; Kaszycki, P. Antioxidant properties of fruits of raspberry and blackberry grown in central Europe. Open Chem. 2015, 13, 1313–1325. [Google Scholar] [CrossRef]
  52. Patras, A.; Brunton, N.P.; Da Pieve, S.; Butler, F. Impact of high pressure processing on total antioxidant activity, phenolic, ascorbic acid, anthocyanin content and colour of strawberry and blackberry purées. Innov. Food Sci. Emerg. Technol. 2009, 10, 308–313. [Google Scholar] [CrossRef]
  53. Martini, S.; Conte, A.; Tagliazucchi, D. Phenolic compounds profile and antioxidant properties of six sweet cherry (Prunus avium) cultivars. Food Res. Int. 2017, 97, 15–26. [Google Scholar] [CrossRef] [PubMed]
  54. Wang, S.; Wang, B.; Dong, K.; Li, J.; Li, Y.; Sun, H. Identification and quantification of anthocyanins of 62 blueberry cultivars via UPLC-MS. Biotechnol. Biotechnol. Equip. 2022, 36, 587–597. [Google Scholar] [CrossRef]
  55. Bushmeleva, K.; Vyshtakalyuk, A.; Terenzhev, D.; Belov, T.; Nikitin, E.; Zobov, V. Antioxidative and immunomodulating properties of Aronia melanocarpa extract rich in anthocyanins. Plants 2022, 11, 3333. [Google Scholar] [CrossRef] [PubMed]
  56. Jakobek, L.; Seruga, M. Influence of anthocyanins, flavonols and phenolic acids on the antiradical activity of berries and small fruits. Int. J. Food Prop. 2012, 15, 122–133. [Google Scholar] [CrossRef]
  57. Šedbarė, R.; Janulis, V.; Ramanauskiene, K. Edible gels with cranberry extract: Evaluation of anthocyanin release kinetics. Gels 2023, 9, 796. [Google Scholar] [CrossRef] [PubMed]
  58. Tendaj, M.; Sawicki, K.; Mysiak, B. The content of some chemical compounds in red cabbage (Brassica oleracea L. var. Capitata F. Rubra) after harvest and long-term storage. Electron. J. Pol. Agric. Univ. 2013, 16, 2. [Google Scholar]
  59. De Araújo, A.C.; Gomes, J.P.; Silva, F.B.; Nunes, J.S.; de Santos, F.S.; Silva, W.P.; Ferreira, J.P.L.; Queiroz, A.J.M.; Figueirêdo, R.M.F.; de Lima, G.S.; et al. Optimization of extraction method of anthocyanins from red cabbage. Molecules 2023, 28, 3549. [Google Scholar] [CrossRef] [PubMed]
  60. Roda-Serrat, M.C.; Razi Parjikolaei, B.; Mohammadifakhr, M.; Martin, J.; Norddahl, B.; Errico, M. A case study for the extraction, purification, and co-pigmentation of anthocyanins from Aronia melanocarpa juice pomace. Foods 2022, 11, 3875. [Google Scholar] [CrossRef] [PubMed]
  61. Dzhanfezova, T.; Barba-Espín, G.; Müller, R.; Joernsgaard, B.; Hegelund, J.N.; Madsen, B.; Larsen, D.H.; Martínez Vega, M.; Toldam-Andersen, T.B. Anthocyanin profile, antioxidant activity and total phenolic content of a strawberry (Fragaria × ananassa Duch) genetic resource collection. Food Biosci. 2020, 36, 620. [Google Scholar] [CrossRef]
  62. Sirijan, M.; Pipattanawong, N.; Saeng-on, B.; Chaiprasart, P. Anthocyanin content, bioactive compounds and physico-chemical characteristics of potential new strawberry cultivars rich in-anthocyanins. J. Berry Res. 2020, 10, 397–410. [Google Scholar] [CrossRef]
  63. Skrovankova, S.; Sumczynski, D.; Mlcek, J.; Jurikova, T.; Sochor, J. Bioactive compounds and antioxidant activity in different types of berries. Int. J. Mol. Sci. 2015, 16, 24673–24706. [Google Scholar] [CrossRef] [PubMed]
  64. Taghavi, T.; Patel, H.; Akande, O.E.; Galam, D.C.A. Total anthocyanin content of strawberry and the profile changes by extraction methods and sample processing. Foods 2022, 11, 1072. [Google Scholar] [CrossRef] [PubMed]
  65. Toshima, S.; Hirano, T.; Kunitake, H. Comparison of anthocyanins, polyphenols, and antioxidant capacities among raspberry, blackberry, and Japanese wild Rubus species. Sci. Hortic. 2021, 285, 110204. [Google Scholar] [CrossRef]
  66. Veberic, R.; Slatnar, A.; Bizjak, J.; Stampar, F.; Mikulic-Petkovsek, M. Anthocyanin composition of different wild and cultivated berry species. LWT 2015, 60, 509–517. [Google Scholar] [CrossRef]
  67. Kapci, B.; Neradová, E.; Čížková, H.; Voldřich, M.; Rajchl, A.; Capanoglu, E. Investigating the antioxidant potential of chokeberry (Aronia melanocarpa) products. J. Food Nutr. Res. 2013, 52, 219–229. [Google Scholar]
  68. Tolić, M.T.; Jurčević, I.L.; Krbavčić, I.P.; Marković, K.; Vahčić, N. Phenolic content, antioxidant capacity and quality of chokeberry (Aronia melanocarpa) products. Food Technol. Biotechnol. 2015, 53, 171–179. [Google Scholar] [CrossRef] [PubMed]
  69. King, E.S.; Bolling, B.W. Composition, polyphenol bioavailability, and health benefits of aronia berry: A review. J. Food Bioact. 2020, 11, 13–30. [Google Scholar] [CrossRef]
  70. Meng, L.; Zhu, J.; Ma, Y.; Sun, X.; Li, D.; Li, L.; Bai, H.; Xin, G.; Meng, X. Composition and antioxidant activity of anthocyanins from Aronia melanocarpa cultivated in Haicheng, Liaoning, China. Food Biosci. 2019, 30, 100413. [Google Scholar] [CrossRef]
  71. Wen, H.; Cui, H.; Tian, H.; Zhang, X.; Ma, L.; Ramassamy, C.; Li, J. Isolation of neuroprotective anthocyanins from black chokeberry (Aronia melanocarpa) against amyloid-β-induced cognitive impairment. Foods 2021, 10, 63. [Google Scholar] [CrossRef] [PubMed]
  72. Roda-Serrat, M.C.; Andrade, T.A.; Rindom, J.; Lund, P.B.; Norddahl, B.; Errico, M. Optimization of the recovery of anthocyanins from chokeberry juice pomace by homogenization in acidified water. Waste Biomass Valor. 2021, 12, 1815–1827. [Google Scholar] [CrossRef]
  73. Raczkowska, E.; Nowicka, P.; Wojdyło, A.; Styczyńska, M.; Lazar, Z. Chokeberry pomace as a component shaping the content of bioactive compounds and nutritional, health-promoting (anti-diabetic and antioxidant) and sensory properties of shortcrust pastries sweetened with sucrose and erythritol. Antioxidants 2022, 11, 190. [Google Scholar] [CrossRef] [PubMed]
  74. Torović, L.; Sazdanić, D.; Atanacković Krstonošić, M.; Mikulić, M.; Beara, I.; Cvejić, J. Compositional characteristics, health benefit and risk of commercial bilberry and black chokeberry juices. Food Biosci. 2023, 51, 102301. [Google Scholar] [CrossRef]
  75. Vlachojannis, C.; Zimmermann, B.F.; Chrubasik-Hausmann, S. Quantification of anthocyanins in elderberry and chokeberry dietary supplements. Phytother. Res. 2015, 29, 561–565. [Google Scholar] [CrossRef] [PubMed]
  76. Dróżdż, P.; Šėžienė, V.; Pyrzynska, K. Phytochemical properties and antioxidant activities of extracts from wild blueberries and lingonberries. Plant Foods Hum. Nutr. 2017, 72, 360–364. [Google Scholar] [CrossRef] [PubMed]
  77. Lätti, A.K.; Riihinen, K.R.; Kainulainen, P.S. Analysis of anthocyanin variation in wild populations of bilberry (Vaccinium myrtillus L.) in Finland. J. Agric. Food Chem. 2008, 56, 190–196. [Google Scholar] [CrossRef] [PubMed]
  78. Garzón, G.A.; Narváez, C.E.; Riedl, K.M.; Schwartz, S.J. Chemical composition, anthocyanins, non-anthocyanin phenolics and antioxidant activity of wild bilberry (Vaccinium meridionale Swartz) from Colombia. Food Chem. 2010, 122, 980–986. [Google Scholar] [CrossRef]
  79. Burdulis, D.; Ivanauskas, L.; Dirsė, V.; Kazlauskas, S.; Ražukas, A. Study of diversity of anthocyanin composition in bilberry (Vaccinium myrtillus L.) fruits. Medicina 2007, 43, 971. [Google Scholar] [CrossRef]
  80. Burdulis, D.; Janulis, V.; Milašius, A.; Jakštas, V.; Ivanauskas, L. Method development for determination of anthocyanidin content in bilberry (Vaccinium myrtillus L.) fruits. J. Liq. Chromatogr. Relat. Technol. 2008, 31, 850–864. [Google Scholar] [CrossRef]
  81. Ponder, A.; Hallmann, E.; Kwolek, M.; Średnicka-Tober, D.; Kazimierczak, R. Genetic differentiation in anthocyanin content among berry fruits. Curr. Issues Mol. Biol. 2021, 43, 36–51. [Google Scholar] [CrossRef]
  82. Veberic, R.; Stampar, F.; Schmitzer, V.; Cunja, V.; Zupan, A.; Koron, D.; Mikulic-Petkovsek, M. Changes in the contents of anthocyanins and other compounds in blackberry fruits due to freezing and long-term frozen storage. Agric. Food Chem. 2014, 62, 6926–6935. [Google Scholar] [CrossRef] [PubMed]
  83. Memete, A.R.; Sărac, I.; Teusdea, A.C.; Budău, R.; Bei, M.; Vicas, S.I. Bioactive compounds and antioxidant capacity of several blackberry (Rubus spp.) fruits cultivars grown in Romania. Horticulturae 2023, 9, 556. [Google Scholar] [CrossRef]
  84. Vieira, L.M.; Guimarães Marinho, L.M.; Rocha, J.; Barros, F.; Stringheta, P. Chromatic analysis for predicting anthocyanin content in fruits and vegetables. Food Sci. Technol. 2019, 39, 415–422. [Google Scholar] [CrossRef]
  85. Šimerdová, B.; Bobríková, M.; Lhotská, I.; Kaplan, J.; Křenová, A.; Šatínský, D. Evaluation of anthocyanin profiles in various blackcurrant cultivars over a three-year period using a fast HPLC-DAD method. Foods 2021, 10, 1745. [Google Scholar] [CrossRef] [PubMed]
  86. Koss-Mikołajczyk, I.; Kusznierewicz, B.; Bartoszek, A. The relationship between phytochemical composition and biological activities of differently pigmented varieties of berry fruits; comparison between embedded in food matrix and isolated anthocyanins. Foods 2019, 8, 646. [Google Scholar] [CrossRef] [PubMed]
  87. Kikas, A.; Rätsep, R.; Kaldmäe, H.; Aluvee, A.; Libek, A.V. Comparison of polyphenols and anthocyanin content of different blackcurrant (Ribes nigrum L.) cultivars at the Polli Horticultural Research Centre in Estonia. Agron. Res. 2020, 18, 2715–2726. [Google Scholar] [CrossRef]
  88. Wagner, A.; Dussling, S.; Nowak, A.; Zimmermann, L.; Bach, P.; Ludwig, M.; Kumar, K.; Will, F.; Schweiggert, R.; Steingass, C.B. Explore all metrics. Investigations into the stability of anthocyanins in model solutions and blackcurrant juices produced with various dejuicing technologies. Eur. Food Res. Technol. 2023, 249, 1771–1784. [Google Scholar] [CrossRef]
  89. Raczkowska, E.; Wojdyło, A.; Nowicka, P. The use of blackcurrant pomace and erythritol to optimise the functional properties of shortbread cookies. Sci. Rep. 2024, 14, 3788. [Google Scholar] [CrossRef] [PubMed]
  90. Lapornik, B.; Prošek, M.; Golc Wondra, A. Comparison of extracts prepared from plant by-products using different solvents and extraction time. J. Food Eng. 2005, 71, 214–222. [Google Scholar] [CrossRef]
  91. Zhao, F.; Wang, J.; Wang, W.; Lyu, L.; Wu, W.; Li, W. The extraction and high antiproliferative effect of anthocyanin from Gardenblue blueberry. Molecules 2023, 28, 2850. [Google Scholar] [CrossRef] [PubMed]
  92. Yang, L.C.; Hsu, S.H.; Meng, Y.Y.; Chen, S.F. Quantification of anthocyanins in blueberries (Vaccinium spp.) by modified QuEChERS and liquid chromatography-mass spectrometry. J. Chin. Chem. Soc. 2022, 69, 1070–1078. [Google Scholar] [CrossRef]
  93. Cásedas, G.; Les, F.; Gómez-Serranillos, M.P.; Smith, C.; López, V. Anthocyanin profile, antioxidant activity and enzyme inhibiting properties of blueberry and cranberry juices: A comparative study. Food Funct. 2017, 8, 4187–4193. [Google Scholar] [CrossRef] [PubMed]
  94. Mulabagal, V.; Lang, G.A.; DeWitt, D.L.; Dalavoy, S.S.; Nair, M.G. Anthocyanin content, lipid peroxidation and cyclooxygenase enzyme inhibitory activities of sweet and sour cherries. J. Agric. Food Chem. 2009, 57, 1239–1246. [Google Scholar] [CrossRef] [PubMed]
  95. Filaferro, M.; Codeluppi, A.; Brighenti, V.; Cimurri, F.; González-Paramás, A.M.; Santos-Buelga, C.; Bertelli, D.; Pellati, F.; Vitale, G. Disclosing the antioxidant and neuroprotective activity of an anthocyanin-rich extract from sweet cherry (Prunus avium L.) using in vitro and in vivo models. Antioxidants 2022, 11, 211. [Google Scholar] [CrossRef] [PubMed]
  96. Enache, I.M.; Vasile, A.M.; Enachi, E.; Barbu, V.; Stănciuc, N.; Vizireanu, C. Co-microencapsulation of anthocyanins from cornelian cherry fruits and lactic acid bacteria in biopolymeric matrices by freeze-drying: Evidences on functional properties and applications in food. Polymers 2020, 12, 906. [Google Scholar] [CrossRef] [PubMed]
  97. Narwojsz, A.; Tańska, M.; Mazur, B.; Borowska, E.J. Fruit physical features, phenolic compounds profile and inhibition activities of cranberry cultivars (Vaccinium macrocarpon) compared to wild-grown cranberry (Vaccinium oxycoccus). Plant Foods Hum. Nutr. 2019, 74, 300–306. [Google Scholar] [CrossRef]
  98. Urbstaite, R.; Raudone, L.; Janulis, V. Phytogenotypic Anthocyanin profiles and antioxidant activity variation in fruit samples of the American cranberry (Vaccinium macrocarpon Aiton). Antioxidants 2022, 11, 250. [Google Scholar] [CrossRef] [PubMed]
  99. Seabra, I.J.; Braga, M.E.M.; Batista, M.T.P.; de Sousa, H.C. Fractioned high pressure extraction of anthocyanins from elderberry (Sambucus nigra L.) pomace. Food Bioprocess. Technol. 2010, 3, 674–683. [Google Scholar] [CrossRef]
  100. da Silva, R.F.R.; Barreira, J.C.M.; Heleno, S.A.; Barros, L.; Calhelha, R.C.; Ferreira, I.C.F.R. Anthocyanin profile of elderberry juice: A natural-based bioactive colouring ingredient with potential food application. Molecules 2019, 24, 2359. [Google Scholar] [CrossRef] [PubMed]
  101. Osman, A.G.; Avula, B.; Katragunta, K.; Ali, Z.; Chittiboyina, A.G.; Khan, I.A. Elderberry extracts: Characterization of the polyphenolic chemical composition, quality consistency, safety, adulteration, and attenuation of oxidative stress- and inflammation-induced health disorders. Molecules 2023, 28, 3148. [Google Scholar] [CrossRef] [PubMed]
  102. Bowen-Forbes, C.S.; Zhang, Y.; Nair, M.G. Anthocyanin content, antioxidant, anti-inflammatory and anticancer properties of blackberry and raspberry fruits. J. Food Compos. Anal. 2010, 23, 554–560. [Google Scholar] [CrossRef]
  103. Paterson, A.; Kassim, A.; McCallum, S.; Woodhead, M.; Smith, K.; Zait, D.; Graham, J. Environmental and seasonal influences on red raspberry flavour volatiles and identification of quantitative trait loci (QTL) and candidate genes. Theor. Appl. Genet. 2013, 126, 33–48. [Google Scholar] [CrossRef] [PubMed]
  104. Koraqi, H.; Ajazi, F.C. Analysis and characterization of anthocyanins in raspberry fruits (Rubus idaeus L.). In Proceedings of the UBT International Conference, Lipjan, Kosovo, 31 October 2020; Available online: https://knowledgecenter.ubt-uni.net/conference/2020/all_events/7 (accessed on 13 March 2024).
  105. Ludwig, I.Z.; Mena, P.; Calani, L.; Borges, G.; Pereira-Caro, G.; Bresciani, L.; Del Rio, D.; Lean, M.E.J.; Crozier, A. New insights into the bioavailability of red raspberry anthocyanins and ellagitannins. Free Radic. Biol. Med. 2015, 89, 758–769. [Google Scholar] [CrossRef] [PubMed]
  106. Nthimole, C.T.; Kaseke, T.; Fawole, O.A. Micro-encapsulation and characterization of anthocyanin-rich raspberry juice powder for potential applications in the food industry. Processes 2022, 10, 1038. [Google Scholar] [CrossRef]
  107. Djordjević, B.; Šavikin, K.; Zdunić, G.; Janković, T.; Vulić, T.; Oparnica, Č.; Radivojević, D. Biochemical properties of red currant varieties in relation to storage. Plant Foods Hum. Nutr. 2010, 65, 326–332. [Google Scholar] [CrossRef] [PubMed]
  108. Benchikh, Y.; Aissaoui, A.; Allouch, R.; Mohellebi, N. Optimising anthocyanin extraction from strawberry fruits using response surface methodology and application in yoghurt as natural colorants and antioxidants. J. Food Sci. Technol. 2021, 58, 1987–1995. [Google Scholar] [CrossRef] [PubMed]
  109. Kumari, A.; Chawla, N.; Singh Dhatt, A. Genotypic differences for anthocyanins in different parts of eggplant (Solanum melongena L.). Int. J. Adv. Res. Biol. Sci. 2018, 5, 12–18. [Google Scholar] [CrossRef]
  110. Colak, N.; Kurt-Celebi, A.; Gruz, J.; Strnad, M.; Hayirlioglu-Ayaz, S.; Choung, M.-G.; Esatbeyoglu, T.; Ayaz, F.A. The phenolics and antioxidant properties of black and purple versus white eggplant cultivars. Molecules 2022, 27, 2410. [Google Scholar] [CrossRef] [PubMed]
  111. Podsędek, A.; Redzynia, M.; Klewicka, E.; Koziołkiewicz, M. Matrix effects on the stability and antioxidant activity of red cabbage anthocyanins under simulated gastrointestinal digestion. Biomed. Res. Int. 2014, 2014, 365738. [Google Scholar] [CrossRef] [PubMed]
  112. Ahmadiani, N.; Robbins, R.J.; Collins, T.M.; Giusti, M.M. Anthocyanins contents, profiles, and color characteristics of red cabbage extracts from different cultivars and maturity stages. Agric. Food Chem. 2014, 62, 7524–7531. [Google Scholar] [CrossRef] [PubMed]
  113. Gachovska, T.; Cassada, D.; Subbiah, J.; Hanna, M.; Thippareddi, H.; Snow, D. Enhanced anthocyanin extraction from red cabbage using pulsed electric field processing. Food Sci. 2010, 75, 6. [Google Scholar] [CrossRef] [PubMed]
  114. Nguyen, N.H.K.; Phuong, L.N.T.; Linh, P.; Truc, T.T.; Cang, M.H. Bioactive compounds from red cabbage by microwave-assisted extraction: Anthocyanins, total phenolic compounds and the antioxidant activity. Asian Life Sci. 2020, 12, 172–184. [Google Scholar]
  115. Ravanfar, R.; Tamadon, A.M.; Niakousari, M. Optimization of ultrasound assisted extraction of anthocyanins from red cabbage using Taguchi design method. J. Food Sci. Technol. 2015, 52, 8140–8147. [Google Scholar] [CrossRef] [PubMed]
  116. Ghareaghajlou, N.; Hallaj-Nezhadi, S.; Ghasempour, Z. Red cabbage anthocyanins: Stability, extraction, biological activities and applications in food systems. Food Chem. 2021, 365, 130482. [Google Scholar] [CrossRef] [PubMed]
  117. Netramai, S.; Kijchavengkul, T.; Samsudin, H.; Lertsiri, S. Enhanced extraction of anthocyanins from red cabbage (Brassica oleraces) using microwave assisted extraction. In Proceedings of the 21st Food Innovation Asia Conference, Bangkok, Thailand, 13–15 June 2019. [Google Scholar]
  118. Kan, L.; Nie, S.; Hu, J.; Wang, S.; Bai, Z.; Wang, J.; Zhou, Y.; Jiang, J.; Zeng, Q.; Song, K. Comparative study on the chemical composition, anthocyanins, tocopherols and carotenoids of selected legumes. Food Chem. 2018, 260, 317–326. [Google Scholar] [CrossRef] [PubMed]
  119. Akond, A.S.M.G.M.; Berthold, J.; Gates, L.; Peters, K.; Delong, H.; Hossain, K. Anthocyanin, total polyphenols and antioxidant activity of common bean. Am. J. Food Technol. 2011, 6, 385–394. [Google Scholar] [CrossRef]
  120. Choung, M.G.; Choi, B.R.; An, Y.N.; Chu, Y.H.; Cho, Y.S. Anthocyanin profile of Korean cultivated kidney bean (Phaseolus vulgaris L.). J. Agric. Food Chem. 2003, 51, 7040–7043. [Google Scholar] [CrossRef]
  121. Anggraini, D.I.; Mirantana, L.P. Determination of anthocyanin level in kidney bean (Phaseolus vulgaris L.) Tempeh as a hepatoprotective agent. J. Farmasi Sains Praktis 2022, 8, 294–301. [Google Scholar] [CrossRef]
  122. Metrani, R.; Singh, J.; Acharya, P.; Jayaprakasha, G.K.; Patil, B.S. Comparative Metabolomics Profiling of Polyphenols, Nutrients and Antioxidant Activities of Two Red Onion (Allium cepa L.) Cultivars. Plants 2020, 9, 1077. [Google Scholar] [CrossRef] [PubMed]
  123. Pérez-Gregorio, R.M.; García-Falcón, M.S.; Simal-Gándara, J.; Rodrigues, A.S.; Almeida, D.P.F. Identification and quantification of flavonoids in traditional cultivars of red and white onions at harvest. J. Food Compos. Anal. 2010, 23, 592–598. [Google Scholar] [CrossRef]
  124. Gennaro, L.; Leonardi, C.; Esposito, F.; Salucci, M.; Maiani, G.; Quaglia, G.; Fogliano, V. Flavonoid and carbohydrate contents in Tropea red onions:  effects of homelike peeling and storage. J. Agric. Food Chem. 2002, 50, 1904–1910. [Google Scholar] [CrossRef] [PubMed]
  125. Stoica, F.; Râpeanu, G.; Nistor, O.V.; Enachi, E.; Stănciuc, N.; Mureșan, C.; Bahrim, G.E. Recovery of bioactive compounds from red onion skins using conventional solvent extraction and microwave assisted extraction. Ann. Univ. Dunarea Galati Fascicle VI Food Technol. 2020, 44, 104–126. [Google Scholar] [CrossRef]
  126. Maryuni, D.R.; Prameswari, D.A.; Astari, S.D.; Sari, S.P.; Putri, D.N. Identification of active compounds in red onion (Allium ascalonicum L.) peel extract by LC-ESI-QTOF-MS/MS and determination of its antioxidant activity. J. Teknol. Has. Pertan. 2022, 15, 20–33. [Google Scholar] [CrossRef]
  127. Koss-Mikołajczyk, I.; Bartoszek, A. Relationship between chemical structure and biological activity evaluated in vitro for six anthocyanidins most commonly occurring in edible plants. Molecules 2023, 28, 6156. [Google Scholar] [CrossRef] [PubMed]
  128. Mattioli, R.; Francioso, A.; Mosca, L.; Silva, P. Anthocyanins: A comprehensive review of their chemical properties and health effects on cardiovascular and neurodegenerative diseases. Molecules 2020, 25, 3809. [Google Scholar] [CrossRef] [PubMed]
  129. Sinopoli, A.; Calogero, G.; Bartolotta, A. Computational aspects of anthocyanidins and anthocyanins: A review. Food Chem. 2019, 297, 124898. [Google Scholar] [CrossRef] [PubMed]
  130. de Lima, A.A.; Sussuchi, E.M.; de Giovani, W.F. Electrochemical and antioxidant properties of anthocyanins and anthocyanidins. Croat. Chem. Acta 2007, 80, 29–34. [Google Scholar]
  131. Yañez-Apam, J.; Domínguez-Uscanga, A.; Herrera-González, A.; Contreras, J.; Mojica, L.; Mahady, G.; Luna-Vital, D.A. Pharmacological activities and chemical stability of natural and enzymatically acylated anthocyanins: A comparative review. Pharmaceuticals 2023, 16, 638. [Google Scholar] [CrossRef] [PubMed]
  132. Fei, P.; Zeng, F.; Zheng, S.; Chen, Q.; Hu, Y.; Cai, J. Acylation of blueberry anthocyanins with maleic acid: Improvement of the stability and its application potential in intelligent color indicator packing materials. Dye. Pigment. 2021, 184, 108852. [Google Scholar] [CrossRef]
  133. Fournier-Level, A.; Hugueney, P.; Verriès, C.; This, P.; Ageorges, A. Genetic mechanisms underlying the methylation level of anthocyanins in grape (Vitis vinifera L.). BMC Plant Biol. 2011, 11, 179. [Google Scholar] [CrossRef] [PubMed]
  134. Xie, L.; Lu, Y.; Zhou, Y.; Hao, X.; Chen, W. Functional analysis of a methyltransferase involved in anthocyanin biosynthesis from blueberries (Vaccinium corymbosum). J. Agric. Food Chem. 2022, 70, 16253–16262. [Google Scholar] [CrossRef] [PubMed]
  135. Pahlke, G.; Ahlberg, K.; Oertel, A.; Janson-Schaffer, T.; Grabher, S.; Mock, H.P.; Matros, A.; Marko, D. Antioxidant effects of elderberry anthocyanins in human colon carcinoma cells: A study on structure-activity relationships. Mol. Nutr. Food Res. 2021, 65, 17. [Google Scholar] [CrossRef]
  136. Chen, J.G.; Wu, S.F.; Zhang, Q.F.; Yin, Z.P.; Zhang, L. α-Glucosidase inhibitory effect of anthocyanins from Cinnamomum camphora fruit: Inhibition kinetics and mechanistic insights through in vitro and in silico studies. Int. J. Biol. Macromol. 2020, 143, 696–703. [Google Scholar] [CrossRef] [PubMed]
  137. Hidalgo, J.; Teuber, S.; Morera, F.J.; Ojeda, C.; Flores, C.A.; Hidalgo, M.A.; Núñez, L.; Villalobos, C.; Burgos, R.A. Delphinidin reduces glucose uptake in mice jejunal tissue and human intestinal cells lines through FFA1/GPR40. Int. J. Mol. Sci. 2017, 18, 750. [Google Scholar] [CrossRef] [PubMed]
  138. Zhu, C.W.; Lü, H.; Du, L.L.; Li, J.; Chen, H.; Zhao, H.F.; Wu, W.L.; Chen, J.; Li, W.L. Five blueberry anthocyanins and their antioxidant, hypoglycemic, and hypolipidemic effects in vitro. Front. Nutr. 2023, 10, 1172982. [Google Scholar] [CrossRef] [PubMed]
  139. Luna-Vital, D.; Weiss, M.; Gonzalez de Mejia, E. Anthocyanins from purple corn ameliorated tumor necrosis factor-α-induced inflammation and insulin resistance in 3t3-l1 adipocytes via activation of insulin signaling and enhanced GLUT4 translocation. Mol. Nutr. Food Res. 2017, 61, 12. [Google Scholar] [CrossRef] [PubMed]
  140. Choi, K.H.; Lee, H.A.; Park, M.H.; Han, J.S. Cyanidin-3-rutinoside increases glucose uptake by activating the PI3K/Akt pathway in 3T3-L1 adipocytes. Environ. Toxicol. Pharmacol. 2017, 54, 1–6. [Google Scholar] [CrossRef] [PubMed]
  141. Yan, F.; Zheng, X. Anthocyanin-rich mulberry fruit improves insulin resistance and protects hepatocytes against oxidative stress during hyperglycemia by regulating AMPK/ACC/mTOR pathway. J. Funct. Foods 2017, 30, 270–281. [Google Scholar] [CrossRef]
  142. Patanè, G.T.; Putaggio, S.; Tellone, E.; Barreca, D.; Ficarra, S.; Maffei, C.; Calderaro, A.; Laganà, G. Catechins and proanthocyanidins involvement in metabolic syndrome. Int. J. Mol. Sci. 2023, 24, 9228. [Google Scholar] [CrossRef] [PubMed]
  143. Huang, W.Y.; Liu, Y.M.; Wang, J.; Wang, X.N.; Li, C.Y. Anti-inflammatory effect of the blueberry anthocyanins malvidin-3-glucoside and malvidin-3-galactoside in endothelial cells. Molecules 2014, 19, 12827–12841. [Google Scholar] [CrossRef] [PubMed]
  144. Warner, E.F.; Smith, M.J.; Zhang, Q.; Raheem, K.S.; O’Hagan, D.; O’Connell, M.A.; Kay, C.D. Signatures of anthocyanin metabolites identified in humans inhibit biomarkers of vascular inflammation in human endothelial cells. Mol. Nutr. Food Res. 2017, 61, 1700053. [Google Scholar] [CrossRef] [PubMed]
  145. Yao, S.L.; Xu, Y.; Zhang, Y.Y.; Lu, Y.H. Black rice and anthocyanins induce inhibition of cholesterol absorption in vitro. Food Funct. 2013, 4, 1602–1608. [Google Scholar] [CrossRef] [PubMed]
  146. Chamnansilpa, N.; Aksornchu, P.; Adisakwattana, S.; Thilavech, T.; Mäkynen, K.; Dahlan, W.; Ngamukote, S. Anthocyanin-rich fraction from Thai berries interferes with the key steps of lipid digestion and cholesterol absorption. Heliyon 2020, 6, e05408. [Google Scholar] [CrossRef] [PubMed]
  147. Thilavech, T.; Adisakwattana, S. Cyanidin-3-rutinoside acts as a natural inhibitor of intestinal lipid digestion and absorption. BMC Complement. Altern. Med. 2019, 19, 242. [Google Scholar] [CrossRef] [PubMed]
  148. Bunea, A.; Rugină, D.; Sconţa, Z.; Pop, R.M.; Pintea, A.; Socaciu, C.; Tăbăran, F.; Grootaert, C.; Struijs, K.; VanCamp, J. Anthocyanin determination in blueberry extracts from various cultivars and their antiproliferative and apoptotic properties in B16-F10 metastatic murine melanoma cells. Phytochemistry 2013, 95, 436–444. [Google Scholar] [CrossRef]
  149. Yan, F.; Dai, G.; Zheng, X. Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice. Nutr. Biochem. 2016, 13, 68–80. [Google Scholar] [CrossRef] [PubMed]
  150. Park, E.; Sozański, T.; Lee, C.G.; Kucharska, A.Z.; Przybylska, D.; Piórecki, N.; Jeong, S.Y. A comparison of the antiosteoporotic effects of cornelian cherry (Cornus mas L.) extracts from red and yellow fruits containing different constituents of polyphenols and iridoids in osteoblasts and osteoclasts. Oxid. Med. Cell. Longev. 2022, 2022, 4122253. [Google Scholar] [CrossRef] [PubMed]
  151. Shindo, M.; Kasai, T.; Abe, A.; Kondo, Y. Effects of dietary administration of plant-derived anthocyanin-rich colors to spontaneously hypertensive rats. J. Nutr. Sci. Vitaminol. 2007, 53, 90–93. [Google Scholar] [CrossRef] [PubMed]
  152. Hogan, S.; Canning, C.; Sun, S.; Sun, X.; Zhou, K. Effects of grape pomace antioxidant extract on oxidative stress and inflammation in diet induced obese mice. J. Agric. Food Chem. 2010, 58, 11250–11256. [Google Scholar] [CrossRef] [PubMed]
  153. Peng, C.H.; Liu, L.K.; Chuang, C.M.; Chyau, C.C.; Huang, C.N.; Wang, C.J. Mulberry water extracts possess an anti-obesity effect and ability to inhibit hepatic lipogenesis and promote lipolysis. J. Agric. Food Chem. 2011, 59, 2663–2671. [Google Scholar] [CrossRef] [PubMed]
  154. Lim, H.H.; Lee, S.O.; Kim, S.Y.; Yang, S.J.; Lim, Y. Anti-inflammatory and antiobesity effects of mulberry leaf and fruit extract on high fat diet-induced obesity. Exp. Biol. Med. 2013, 238, 1160–1169. [Google Scholar] [CrossRef] [PubMed]
  155. Jurgoński, A.; Juśkiewicz, J.; Zduńczyk, Z. An anthocyanin-rich extract from Kamchatka honeysuckle increases enzymatic activity within the gut and ameliorates abnormal lipid and glucose metabolism in rats. Nutrition 2013, 29, 898–902. [Google Scholar] [CrossRef] [PubMed]
  156. Vendrame, S.; Daugherty, A.; Kristo, A.S.; Riso, P.; Klimis-Zacas, D. Wild blueberry (Vaccinium angustifolium) consumption improves inflammatory status in the obese Zucker rat model of the metabolic syndrome. J. Nutr. Biochem. 2013, 24, 1508–1512. [Google Scholar] [CrossRef] [PubMed]
  157. Wu, T.; Yu, Z.; Tang, Q.; Song, H.; Gao, Z.; Chen, W.; Zheng, X. Honeysuckle anthocyanin supplementation prevents diet-induced obesity in C57BL/6 mice. Food Funct. 2013, 4, 1654–1661. [Google Scholar] [CrossRef] [PubMed]
  158. Zhang, Z.F.; Lu, J.; Zheng, Y.L.; Wu, D.M.; Hu, B.; Shan, Q.; Cheng, W.; Li, M.Q.; Sun, Y.Y. Purple sweet potato color attenuates hepatic insulin resistance via blocking oxidative stress and endoplasmic reticulum stress in high-fat-diet-treated mice. J. Nutr. Biochem. 2013, 24, 1008–1018. [Google Scholar] [CrossRef] [PubMed]
  159. Sozański, T.; Kucharska, A.Z.; Szumnyc, A.; Magdalan, K.; Bielska, K.; Merwid-Ląd, A.; Wozniak, A.; Dzimira, S.; Piórecki, N.; Trocha, M. The protective effect of the Cornus mas fruits (cornelian cherry) on hypertriglyceridemia and atherosclerosis through PPAR activation in hypercholesterolemic rabbits. Phytomedicine 2014, 21, 1774–1784. [Google Scholar] [CrossRef]
  160. Daskalova, E.; Delchev, S.; Peeva, Y.; Vladimirova-Kitova, L.; Kratchanova, M.; Kratchanov, C.; Denev, P. Antiatherogenic and Cardioprotective Effects of Black Chokeberry (Aronia melanocarpa) Juice in Aging Rats. Evid. Based Complement. Alternat. Med. 2015, 2015, 717439. [Google Scholar] [CrossRef] [PubMed]
  161. Park, J.H.; Kho, M.C.; Kim, H.Y.; Ahn, Y.M.; Lee, Y.J.; Kang, D.G.; Lee, H.S. Blackcurrant Suppresses Metabolic Syndrome Induced by High-Fructose Diet in Rats. Evid. Based Complement. Alternat. Med. 2015, 2015, 385976. [Google Scholar] [CrossRef] [PubMed]
  162. Sozański, T.; Kucharska, A.Z.; Rapak, A.; Szumny, D.; Trocha, M.; Merwid-Ląd, A.; Dzimira, S.; Piasecki, T.; Piorecki, N.; Magdalan, J.; et al. Iridoideloganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): Common and different effects on diet-induced atherosclerosis, PPARs expression and inflammation. Atherosclerosis 2016, 254, 151–160. [Google Scholar] [CrossRef]
  163. Wu, T.; Yin, J.; Zhang, G.; Long, H.; Zheng, X. Mulberry and cherry anthocyanin consumption prevents oxidative stress and inflammation in diet-induced obese mice. Mol. Nutr. Food Res. 2016, 60, 687–694. [Google Scholar] [CrossRef] [PubMed]
  164. Wu, T.; Guo, X.; Zhang, M.; Yang, L.; Liu, R.; Yin, J. Anthocyanins in black rice, soybean and purple corn increase fecal butyric acid and prevent liver inflammation in high fat diet-induced obese mice. Food Funct. 2017, 8, 3178–3186. [Google Scholar] [CrossRef] [PubMed]
  165. Yamane, T.; Kozuka, M.; Imai, M.; Yamamoto, Y.; Ohkubo, I.; Sakamoto, T.; Nakagaki, T.; Nakano, Y. Reduction of blood pressure by aronia berries through inhibition of angiotensin-converting enzyme activity in the spontaneously hypertensive rat kidney. Funct. Food Health Dis. 2017, 7, 280–290. [Google Scholar] [CrossRef]
  166. Peixoto, T.C.; Moura, E.G.; de Oliveira, E.; Soares, P.N.; Guarda, D.S.; Bernardino, D.N.; Ai, X.X.; Rodrigues, V.D.S.T.; de Souza, G.R.; da Silva, A.J.R.; et al. Cranberry (Vaccinium macrocarpon) extract treatment improves triglyceridemia, liver cholesterol, liver steatosis, oxidative damage and corticosteronemia in rats rendered obese by high fat diet. Eur. J. Nutr. 2018, 57, 1829–1844. [Google Scholar] [CrossRef] [PubMed]
  167. Buko, V.; Zavodnik, I.; Kanuka, O.; Belonovskaya, E.; Naruta, E.; Lukivskaya, O.; Kirko, S.; Budryn, G.; Żyżelewicz, D.; Oracze, J.; et al. Antidiabetic effects and erythrocyte stabilization by red cabbage extract in streptozotocin-treated rats. Food Funct. 2018, 9, 1850–1863. [Google Scholar] [CrossRef] [PubMed]
  168. Zhang, Z.; Zhou, Q.; Huangfu, G.; Wu, Y.; Zhang, J. Anthocyanin extracts of lingonberry (Vaccinium vitis-idaea L.) attenuate serum lipids and cholesterol metabolism in HCD-induced hypercholesterolaemic male mice. Int. J. Food Sci. Technol. 2019, 54, 1576–1587. [Google Scholar] [CrossRef]
  169. Wu, T.; Yang, L.; Guo, X.; Zhang, M.; Liu, R.; Sui, W. Raspberry anthocyanin consumption prevents diet-induced obesity by alleviating oxidative stress and modulating hepatic lipid metabolism. Food Funct. 2018, 9, 2112–2120. [Google Scholar] [CrossRef] [PubMed]
  170. Capcarova, M.; Kalafova, M.; Schwarzova, M.; Schneidgenova, M.; Svik, K.; Soltesova Prnovac, M.; Slovak, L.; Kovacik, A.; Lory, V.; Zorad, S.; et al. Cornelian cherry fruit improves glycaemia and manifestations of diabetes in obese Zucker diabetic fatty rats. Res. Vet. Sci. 2019, 126, 118–123. [Google Scholar] [CrossRef] [PubMed]
  171. Dzydzan, O.; Bila, I.; Kucharska, A.Z.; Brodyak, I.; Sybirna, N. Antidiabetic effects of extracts of red and yellow fruits of cornelian cherries (Cornus mas L.) on rats with streptozotocin-induced diabetes mellitus. Food Funct. 2019, 10, 6459–6472. [Google Scholar] [CrossRef] [PubMed]
  172. Herawati, E.R.N.; Santosa, U.; Sentana, S.; Ariani, D. Protective effects of anthocyanin extract from purple sweet potato (Ipomoea batatas L.) on blood MDA levels, liver and renal activity, and blood pressure of hyperglycemic rats. Prev. Nutr. Food Sci. 2020, 25, 375–379. [Google Scholar] [CrossRef] [PubMed]
  173. Strugała, P.; Dzydzan, O.; Brodyak, I.; Kucharska, A.Z.; Kuropka, P.; Liuta, M.; Kaleta-Kuratewicz, K.; Przewodowska, A.; Michałowska, D.; Gabrielska, J.; et al. Antidiabetic and antioxidative potential of the Blue Congo variety of purple potato extract in streptozotocin-induced diabetic rats. Molecules 2019, 24, 3126. [Google Scholar] [CrossRef] [PubMed]
  174. Song, H.; Shen, X.; Zhou, Y.; Zheng, X. Black rice anthocyanins alleviate hyperlipidemia, liver steatosis and insulin resistance by regulating lipid metabolism and gut microbiota in obese mice. Food Funct. 2021, 12, 10160–10170. [Google Scholar] [CrossRef]
  175. Song, H.; Shen, X.; Wang, F.; Li, Y.; Zheng, X. Black current anthocyanins improve lipid metabolism and modulate gut microbiota in high-fat diet-induced obese mice. Mol. Nutr. Food Red. 2021, 65, 6. [Google Scholar] [CrossRef] [PubMed]
  176. Li, N.; Liu, X.; Zhang, J.; Lang, Y.Z.; Lu, L.; Mi, J.; Cao, Y.L.; Yan, Y.M.; Ran, L.-W. Preventive effects of anthocyanins from Lycium ruthenicum Murray in high-fat diet-induced obese mice are related to the regulation of intestinal microbiota and inhibition of pancreatic lipase activity. Molecules 2022, 27, 2141. [Google Scholar] [CrossRef] [PubMed]
  177. Herrera-Balandrano, D.D.; Chai, Z.; Hutabarat, R.P.; Beta, T.; Feng, J.; Ma, K.; Li, D.; Huang, W. Hypoglycemic and hypolipidemic effects of blueberry anthocyanins by AMPK activation: In vitro and in vivo studies. Redox Biol. 2021, 46, 102100. [Google Scholar] [CrossRef] [PubMed]
  178. Ugwu, P.; Ubom, R.; Madueke, P.; Okorie, P.; Nwachukwu, D. Anti-hypertensive effects of anthocyanins from Hibiscus sabdarifa calyx on the renin-angiotensin-aldosterone system in Wistar rats. Niger. J. Physiol. Sci. 2022, 37, 113–117. [Google Scholar] [CrossRef] [PubMed]
  179. Xu, C.; Zhu, J.; Gong, G.; Guo, L.; Zhang, Y.; Zhang, Z.; Ma, C. Anthocyanin attenuates high salt-induced hypertension via inhibiting the hyperactivity of the sympathetic nervous system. Clin. Exp. Hypertens. 2023, 45, 2233717. [Google Scholar] [CrossRef] [PubMed]
  180. Wang, J.; Zhu, C.; Qian, T.; Guo, H.; Wang, D.; Zhang, F.; Yin, X. Extracts of black bean peel and pomegranate peel ameliorate oxidative stress-induced hyperglycemia in mice. Exp. Ther. Med. 2015, 9, 43–48. [Google Scholar] [CrossRef] [PubMed]
  181. Wang, J.; Zhao, X.; Zheng, J.; Herrera-Balandrano, D.D.; Zhang, X.; Huang, W.; Sui, Z. In vivo antioxidant activity of rabbiteye blueberry (Vaccinium ashei cv. ‘Brightwell’) anthocyanin extracts. J. Zhejiang Univ. Sci. 2023, B 24, 602–616. [Google Scholar] [CrossRef]
  182. Asemota, K.E.; Uyovwiesevwa, A.J.; Omoirri, M.A.; Olowe, G.T. Free radical scavenging activities of anthocyanin flavonoid. World J. Biol. Pharm. Health Sci. 2020, 4, 13–20. [Google Scholar] [CrossRef]
  183. Çoban, J.; Evran, B.; Özkan, F.; Çevık, A.; Doğru-Abbasoğlu, S.; Uysal, M. Effect of blueberry feeding on lipids and oxidative stress in the serum, liver and aorta of guinea pigs fed on a high-cholesterol diet. Biosci. Biotechnol. Biochem. 2013, 77, 389–391. [Google Scholar] [CrossRef] [PubMed]
  184. Shishehbor, F.; Azemi, M.E.; Zameni, D.; Saki, A. Inhibitory effect of hydroalcoholic extracts of barberry, sour cherry and cornelian cherry on α-amylase and α-glucosidase activities. Int. J. Pharm. Res. Allied Sci. 2016, 5, 423–428. [Google Scholar]
  185. Jiang, T.; Shuai, X.; Li, J.; Yang, N.; Deng, L.; Li, S.; He, Y.; Guo, H.; Li, Y.; He, J. Protein-bound anthocyanin compounds of purple sweet potato ameliorate hyperglycemia by regulating hepatic glucose metabolism in high-fat diet/streptozotocin-induced diabetic mice. J. Agric. Food Chem. 2020, 68, 1596–1608. [Google Scholar] [CrossRef] [PubMed]
  186. Chen, C.; Yang, X.; Liu, S.; Zhang, M.; Wang, C.; Xia, X.; Loua, Y.; Xu, H. The effect of lipid metabolism regulator anthocyanins from Aronia melanocarpa on 3T3-L1 preadipocytes and C57BL/6 mice via activating AMPK signaling and gut microbiota. Food Funct. 2021, 12, 6254–6270. [Google Scholar] [CrossRef] [PubMed]
  187. Gao, Q.; Ma, R.; Shi, L.; Wang, S.; Liang, Y.; Zhang, Z. Anti-glycation and anti-inflammatory activities of anthocyanins from purple vegetables. Food Funct. 2023, 14, 2034–2044. [Google Scholar] [CrossRef] [PubMed]
  188. Pomilio, A.B.; Szewczuk, N.A.; Duchowicz, P.R. Dietary anthocyanins balance immune signs in osteoarthritis and obesity—Update of human in vitro studies and clinical trials. Crit. Rev. Food Sci. Nutr. 2022, 23, 1–39. [Google Scholar] [CrossRef] [PubMed]
  189. Ngamsamer, C.; Sirivarasai, J.; Sutjarit, N. The benefits of anthocyanins against obesity-induced inflammation. Biomolecules 2022, 12, 852. [Google Scholar] [CrossRef]
  190. Tong, Y.; Li, L.; Meng, X. Anthocyanins from Aronia melanocarpa Bound to Amylopectin Nanoparticles: Tissue Distribution and In Vivo Oxidative Damage Protection. J. Agric. Food Chem. 2023, 71, 430–442. [Google Scholar] [CrossRef]
  191. Calderaro, A.; Barreca, D.; Bellocco, E.; Smeriglio, A.; Trombetta, D.; Laganà, G. Chapter Eight—Colored phytonutrients: Role and applications in the functional foods of anthocyanins. In Phytonutrients in Food; Nabavi, S.M., Suntar, I., Barreca, D., Khan, H., Eds.; Woodhead Publishing: Sawston, UK, 2020; pp. 177–195. [Google Scholar]
  192. Wrolstad, R.E.; Durst, R.W.; Lee, J. Tracking color and pigment changes in anthocyanin products. Trends Food Sci. Technol. 2005, 16, 423–428. [Google Scholar] [CrossRef]
  193. Park, S.; Choi, M.; Lee, M. Effects of anthocyanin supplementation on reduction of obesity criteria: A systematic review and meta-analysis of randomized controlled trials. Nutrients 2021, 13, 2121. [Google Scholar] [CrossRef] [PubMed]
  194. Neyestani, T.R.; Yari, Z.; Rasekhi, H.; Nikooyeh, B. How effective are anthocyanins on healthy modification of cardiometabolic risk factors: A systematic review and meta-analysis. Diabetol. Metab. Syndr. 2023, 15, 106. [Google Scholar] [CrossRef] [PubMed]
  195. Basu, A.; Du, M.; Leyva, M.J.; Sanchez, K.; Betts, N.M.; Wu, M.; Aston, C.E.; Lyons, T.J. Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J. Nutr. 2010, 140, 1582–1587. [Google Scholar] [CrossRef] [PubMed]
  196. Aboonabi, A.; Singh, I.; Rose’ Meyer, R. Cytoprotective effects of berry anthocyanins against induced oxidative stress and inflammation in primary human diabetic aortic endothelial cells. Chem. Biol. Interact. 2020, 317, 108940. [Google Scholar] [CrossRef] [PubMed]
  197. Asgary, S.; Kelishadi, R.; Rafieian-Kopaei, M.; Najafi, S.; Najafi, M.; Sahebkar, A. Investigation of the lipid-modifying and antiinflammatory effects of Cornus mas L. supplementation on dyslipidemic children and adolescents. Pediatr. Cardiol. 2013, 34, 1729–1735. [Google Scholar] [CrossRef] [PubMed]
  198. Wright, O.R.; Netzel, G.A.; Sakzewski, A.R. A randomized, double-blind, placebo-controlled trial of the effect of dried purple carrot on body mass, lipids, blood pressure, body composition, and inflammatory markers in overweight and obese adults: The QUENCH trial. Can. J. Physiol. Pharmacol. 2013, 91, 480–488. [Google Scholar] [CrossRef] [PubMed]
  199. Basu, A.; Betts, N.M.; Nguyen, A.; Newman, E.D.; Fu, D.; Lyons, T.J. Freeze-dried strawberries lower serum cholesterol and lipid peroxidation in adults with abdominal adiposity and elevated serum lipids. J. Nutr. 2014, 144, 830–837. [Google Scholar] [CrossRef] [PubMed]
  200. Aghababaee, S.K.; Vafa, M.; Shidfar, F.; Tahavorgar, A.; Gohari, M.; Katebi, D.; Mohammadi, V. Effects of blackberry (Morus nigra L.) consumption on serum concentration of lipoproteins, apo A-I, apo B, and high-sensitivity-C-reactive protein and blood pressure in dyslipidemic patients. J. Res. Med. Sci. 2015, 20, 685–691. [Google Scholar] [CrossRef]
  201. Li, D.; Zhang, Y.; Liu, Y.; Sun, R.; Xia, M. Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J. Nutr. 2015, 145, 742–748. [Google Scholar] [CrossRef] [PubMed]
  202. Novotny, J.A.; Baer, D.J.; Khoo, C.; Gebauer, S.K.; Charron, C.S. Cranberry juice consumption lowers markers of cardiometabolic risk, including blood pressure and circulating c-reactive protein, triglyceride, and glucose concentrations in adults. J. Nutr. 2015, 145, 1185–1193. [Google Scholar] [CrossRef] [PubMed]
  203. Zhang, P.W.; Chen, F.X.; Li, D.; Ling, W.H.; Guo, H.H. A CONSORT-compliant, randomized, double-blind, placebo-controlled pilot trial of purified anthocyanin in patients with nonalcoholic fatty liver disease. Medicine 2015, 94, e758. [Google Scholar] [CrossRef] [PubMed]
  204. Habanova, M.; Saraiva, J.A.; Haban, M.; Schwarzova, M.; Chlebo, P.; Predna, L.; Gažo, J.; Wyka, J. Intake of bilberries (Vaccinium myrtillus L.) reduced risk factors for cardiovascular disease by inducing favorable changes in lipoprotein profiles. Nutr. Res. 2016, 36, 1415–1422. [Google Scholar] [CrossRef] [PubMed]
  205. Lee, M.; Sorn, S.R.; Park, T.; Park, H.K. Anthocyanin rich-black soybean testa improved visceral fat and plasma lipid profiles in overweight/obese Korean adults: A randomized controlled trial. J. Med. Food 2016, 19, 995–1003. [Google Scholar] [CrossRef] [PubMed]
  206. Azzini, E.; Venneria, E.; Ciarapica, D.; Foddai, M.S.; Intorre, F.; Zaccaria, M.; Maiani, F.; Palomba, L.; Barnaba, L.; Tubili, C.; et al. Effect of red orange juice consumption on body composition and nutritional status in overweight/obese female: A pilot study. Oxid. Med. Cell. Longev. 2017, 2017, 1672567. [Google Scholar] [CrossRef] [PubMed]
  207. Paquette, M.; Larque, A.S.M.; Weisnagel, S.J.; Desjardins, Y.; Marois, J.; Pilon, G.; Dudonne, S.; Marette, A.; Jacques, H. Strawberry and cranberry polyphenols improve insulin sensitivity in insulin-resistant, non-diabetic adults: A parallel, double-blind, controlled and randomised clinical trial. Br. J. Nutr. 2017, 117, 519–531. [Google Scholar] [CrossRef] [PubMed]
  208. Xie, L.; Vance, T.; Kim, B.; Lee, S.G.; Caceres, C.; Wang, Y.; Hubert, P.A.; Lee, J.Y.; Chun, O.K.; Bolling, B.W. Aronia berry polyphenol consumption reduces plasma total and low-density lipoprotein cholesterol in former smokers without lowering biomarkers of inflammation and oxidative stress: A randomized controlled trial. Nutr. Res. 2017, 37, 67–77. [Google Scholar] [CrossRef] [PubMed]
  209. Solverson, P.M.; Rumpler, W.V.; Leger, J.L.; Redan, B.W.; Ferruzzi, M.G.; Baer, D.J.; Castonguay, T.W.; Novotny, J.A. Blackberry feeding increases fat oxidation and improves insulin sensitivity in overweight and obese males. Nutrients 2018, 10, 1048. [Google Scholar] [CrossRef] [PubMed]
  210. Curtis, P.J.; Van Der Velpen, V.; Berends, L.; Jennings, A.; Feelisch, M.; Umpleby, A.M.; Evans, M.; Fernandez, B.O.; Meiss, M.S.; Minnion, M.; et al. Blueberries improve biomarkers of cardiometabolic function in participants with metabolic syndrome-results from a 6-month; double-blind; randomized controlled trial. Am. J. Clin. Nutr. 2019, 109, 1535–1545. [Google Scholar] [CrossRef] [PubMed]
  211. Habanova, M.; Saraiva, J.A.; Holovicova, M.; Moreira, S.A.; Fidalgo, L.G.; Haban, M.; Gazo, J.; Schwarzova, M.; Chlebo, P.; Bronkowska, M. Effect of berries/apple mixed juice consumption on the positive modulation of human lipid profile. J. Funct. Foods 2019, 60, 103417. [Google Scholar] [CrossRef]
  212. Pokimica, B.; García-Conesa, M.T.; Zec, M.; Debeljak-Martačić, J.; Ranković, S.; Vidović, N.; Petrović-Oggiano, P.; Konić-Ristić, A.; Glibetić, M. Chokeberry juice containing polyphenols does not affect cholesterol or blood pressure but modifies the composition of plasma phospholipids fatty acids in individuals at cardiovascular risk. Nutrients 2019, 11, 850. [Google Scholar] [CrossRef] [PubMed]
  213. Nolan, A.; Brett, R.; Strauss, J.A.; Stewart, C.E.; Shepherd, S.O. Short-term, but not acute, intake of New Zealand blackcurrant extract improves insulin sensitivity and free-living postprandial glucose excursions in individuals with overweight or obesity. Eur. J. Nutr. 2021, 60, 1253–1262. [Google Scholar] [CrossRef] [PubMed]
  214. Aboonabi, A.; Meyer, R.R.; Gaiz, A.; Singh, I. Anthocyanins in berries exhibited antiatherogenicity and antiplatelet activities in a metabolic syndrome population. Nutr. Res. 2020, 76, 82–93. [Google Scholar] [CrossRef]
  215. Aboonabi, A.; Aboonabi, A. Anthocyanins reduce inflammation and improve glucose and lipid metabolism associated with inhibiting nuclear factor-kappaB activation and increasing PPAR-γ gene expression in metabolic syndrome subjects. Free Rad. Biol. Med. 2020, 150, 30–39. [Google Scholar] [CrossRef] [PubMed]
  216. Sangouni, A.A.; Sangsefid, S.Z.; Yarhosseini, F.; Hosseinzadeh, M.; Akhondi-Meybodi, M.; Ranjbar, A.; Madadizadeh, M.; Mozaffari-Khosravi, H. Effect of Cornus mas L. fruit extract on lipid accumulation product and cardiovascular indices in patients with non-alcoholic fatty liver disease: A double-blind randomized controlled trial. Clin. Nutr. ESPEN 2022, 47, 51–57. [Google Scholar] [CrossRef] [PubMed]
  217. Masheta, D.Q.; Al-Azzawi, S.K.; Abbood, S.F. Anti-inflammatory activity of anthocyanin extract on diabetic and hypertensive patients. Sci. Pharm. Sci. 2023, 2, 68–74. [Google Scholar] [CrossRef]
  218. Basu, A.; Betts, N.M.; Ortiz, J.; Simmons, B.; Wu, M.; Lyons, T.J. Low-energy cranberry juice decreases lipid oxidation and increases plasma antioxidant capacity in women with metabolic syndrome. Nutr. Res. 2011, 31, 190–196. [Google Scholar] [CrossRef] [PubMed]
  219. Kuntz, S.; Kunz, C.; Herrmann, J.; Borsch, C.H.; Abel, G.; Fröhling, B.; Dietrich, H.; Rudloff, S. Anthocyanins from fruit juices improve the antioxidant status of healthy young female volunteers without affecting anti-inflammatory parameters: Results from the randomised, double-blind, placebo-controlled, cross-over ANTHONIA (ANTHOcyanins in Nutrition Investigation Alliance) study. Brit J. Nutr. 2014, 112, 925–936. [Google Scholar] [CrossRef] [PubMed]
  220. Zhang, X.; Rehman, R.; Wang, S.; Ji, Y.; Li, J.; Liu, S.; Wang, H. Blue honeysuckle extracts retarded starch digestion by inhibiting glycosidases and changing the starch structure. Food Funct. 2022, 13, 6072–6088. [Google Scholar] [CrossRef] [PubMed]
  221. Li, Z.; Tian, J.; Cheng, Z.; Teng, W.; Zhang, W.; Bao, Y.; Wang, Y.; Song, B.; Chen, Y.; Li, B. Hypoglycemic bioactivity of anthocyanins: A review on proposed targets and potential signaling pathways. Crit. Rev. Food Sci. Nutr. 2023, 63, 7878–7895. [Google Scholar] [CrossRef] [PubMed]
  222. Solverson, P.M.; Henderson, T.R.; Debelo, H.; Ferruzzi, M.G.; Baer, D.J.; Novotny, J.A. An Anthocyanin-rich mixed-berry intervention may improve insulin sensitivity in a randomized trial of overweight and obese adults. Nutrients 2019, 11, 2876. [Google Scholar] [CrossRef] [PubMed]
  223. Lin Lee, J.J.; Chan, B.; Chun, C.; Bhaskaran, K.; Chen, W.N. A preparation of β-glucans and anthocyanins (LoGiCarb™) lowers the in vitro digestibility and in vivo glycemic index of white rice. RSC Adv. 2020, 10, 5129–5133. [Google Scholar] [CrossRef] [PubMed]
  224. Kolehmainen, M.; Mykkänen, O.; Kirjavainen, P.V.; Leppänen, T.; Moilanen, E.; Adriaens, M.; Laaksonen, D.E.; Hallikainen, M.; Puupponen-Pimiä, R.; Pulkkinen, L.; et al. Bilberries reduce low-grade inflammation in individuals with features of metabolic syndrome. Mol. Nutr. Food Res. 2012, 56, 1501–1510. [Google Scholar] [CrossRef]
  225. Araki, R.; Yada, A.; Ueda, H.; Tominaga, K.; Isoda, H. Differences in the effects of anthocyanin supplementation on glucose and lipid metabolism according to the structure of the main anthocyanin: A meta-analysis of randomized controlled trials. Nutrients 2021, 13, 2003. [Google Scholar] [CrossRef] [PubMed]
  226. Djuricic, I.; Calder, P.C. Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021. Nutrients 2021, 13, 2421. [Google Scholar] [CrossRef]
  227. Carta, G.; Murru, E.; Banni, S.; Manca, C. Palmitic acid: Physiological role, metabolism and nutritional implications. Front. Physiol. 2017, 8, 902. [Google Scholar] [CrossRef] [PubMed]
  228. Gao, C. Inhibitory Effects of Berry Anthocyanins on Palmitic Acid- or Lipopolysaccharide- Induced Inflammation in Human Preadipocytes. Master’s Thesis, Louisiana State University, Baton Rouge, LA, USA, 2011; p. 1569. Available online: https://repository.lsu.edu/gradschool_theses/1569 (accessed on 13 March 2024).
  229. Speciale, A.; Bashllari, R.; Muscarà, C.; Molonia, M.S.; Saija, A.; Saha, S.; Wilde, P.J.; Cimino, F. Anti-inflammatory activity of an in vitro digested anthocyanin-rich extract on intestinal epithelial cells exposed to TNF-α. Molecules 2022, 27, 5368. [Google Scholar] [CrossRef] [PubMed]
  230. Khoo, H.E.; Azlan, A.; Tang, S.T.; Lim, S.M. Anthocyanidins and anthocyanins: Colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr. Res. 2017, 61, 1361779. [Google Scholar] [CrossRef] [PubMed]
  231. Lee, Y.M.; Yoon, Y.; Yoon, H.; Park, H.M.; Song, S.; Yeum, K.J. Dietary Anthocyanins against Obesity and Inflammation. Nutrients 2017, 9, 1089. [Google Scholar] [CrossRef] [PubMed]
  232. Speciale, A.; Saija, A.; Bashllari, R.; Molonia, M.S.; Muscarà, C.; Occhiuto, C.; Cimino, F.; Cristani, M. Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases. Curr. Med. Chem. 2020, 27, 1955–1996. [Google Scholar] [CrossRef] [PubMed]
  233. Yildiz, E.; Guldas, M.; Ellergezen, P.; Gul Acar, A.; Gurbuz, A. Obesity-associated pathways of anthocyanins. Food Sci. Technol. 2021, 41. [Google Scholar] [CrossRef]
  234. Istek, N.; Gurbuz, O. Investigation of the impact of blueberries on metabolic factors influencing health. J. Funct. Foods 2017, 38, 298–307. [Google Scholar] [CrossRef]
  235. Tiwari, V.; Sharma, S.; Tiwari, A.; Sheoran, B.; Kaur, S.; Sharma, A.; Yadav, M.; Bhatnagar, A.; Garg, M. Effect of dietary anthocyanins on biomarkers of type 2 diabetes and related obesity: A systematic review and meta-analysis. Crit. Rev. Food Sci. Nutr. 2023, 1–18. [Google Scholar] [CrossRef] [PubMed]
  236. Bertoia, M.L.; Rimm, E.B.; Mukamal, K.J.; Hu, F.B.; Willett, W.C.; Cassidy, A. Dietary flavonoid intake and weight maintenance: Three prospective cohorts of 124086 US men and women followed for up to 24 years. BMJ 2016, 352, i17. [Google Scholar] [CrossRef] [PubMed]
  237. Budiarto, D.; Wijianto, B.; IH, H. Study of anthocyanin molecule blocking as anti-hypertensive through the pathway of the renin-angiotensin-aldosterone system (RAAS). Indo. J. Chem. Res. 2023, 11, 49–58. [Google Scholar] [CrossRef]
  238. Godos, J.; Vitale, M.; Micek, A.; Ray, S.; Martini, D.; Del Rio, D.; Riccardi, G.; Galvano, F.; Grosso, G. Dietary polyphenol intake, blood pressure, and hypertension: A systematic review and meta-analysis of observational studies. Antioxidants 2019, 8, 152. [Google Scholar] [CrossRef] [PubMed]
  239. Ahles, S.; Joris, P.J.; Plat, J. Effects of berry anthocyanins on cognitive performance, vascular function and cardiometabolic risk markers: A systematic review of randomized placebo-controlled intervention studies in humans. Int. J. Mol. Sci. 2021, 22, 6482. [Google Scholar] [CrossRef] [PubMed]
  240. Olivas-Aguirre, F.J.; Rodrigo-García, J.; Martínez-Ruiz, N.d.R.; Cárdenas-Robles, A.I.; Mendoza-Díaz, S.O.; Álvarez-Parrilla, E.; González-Aguilar, G.A.; de la Rosa, L.A.; Ramos-Jiménez, A.; Wall-Medrano, A. Cyanidin-3-O-glucoside: Physical-chemistry, foodomics and health effects. Molecules 2016, 21, 1264. [Google Scholar] [CrossRef] [PubMed]
  241. Akhtar, S.; Rauf, A.; Imran, M.; Qamar, M.; Riaz, M.; Mubarak, M.S. Black carrot (Daucus carota L.), dietary and health promoting perspectives of its polyphenols: A review. Trends Food Sci. Technol. 2017, 66, 36–47. [Google Scholar] [CrossRef]
  242. Fairlie-Jones, L.; Davison, K.; Fromentin, E.; Hill, A.M. The effect of anthocyanin-rich foods or extracts on vascular function in adults: A systematic review and meta-analysis of randomised controlled trials. Nutrients 2017, 20, 908. [Google Scholar] [CrossRef] [PubMed]
  243. Rodriguez-Mateos, A.; Heiss, C.; Borges, G.; Crozier, A. Berry (poly)phenols and cardiovascular health. J. Agric. Food Chem. 2014, 62, 3842–3851. [Google Scholar] [CrossRef] [PubMed]
  244. Kruger, M.J.; Davies, N.; Myburgh, K.H.; Lecour, S. Proanthocyanidins, anthocyanins and cardiovascular diseases. Food Res. Int. 2014, 59, 41–52. [Google Scholar] [CrossRef]
  245. Ponzo, V.; Goitre, I.; Fadda, M.; Gambino, R.; De Francesco, A.; Soldati, L.; Gentile, L.; Magistroni, P.; Cassander, M.; Bo, S. Dietary flavonoid intake and cardiovascular risk: A population-based cohort study. J. Transl. Med. 2015, 13, 218. [Google Scholar] [CrossRef]
Figure 2. Chemical structure of some mono- or di-glycosylated anthocyanins.
Figure 2. Chemical structure of some mono- or di-glycosylated anthocyanins.
Nutrients 16 01103 g002aNutrients 16 01103 g002b
Table 1. Diagnostic criteria for metabolic syndrome [23].
Table 1. Diagnostic criteria for metabolic syndrome [23].
Necessary Condition for Diagnosis
Diagnosed android obesityWC > 102 cm (men) and >88 cm (women)
or BMI ≥ 30 kg/m2
At least two of the following are required
Disordered carbohydrate metabolismFG ≥ 100 mg/dL
or OGTT2h ≥ 140 mg/dL
or HbA1c ≥ 5.7%
or treatment started
Arterial hypertensionSBP ≥ 130 mmHg
or DBP ≥ 85 mmHg
or (home measurement):
SBP ≥ 130 mmHg or
DBP ≥ 80 mmHg
or treatment started
DyslipidaemiaNon-HDLc ≥ 130 mg/dL
or use of hypolipidaemic treatment
Abbreviations: BMI, body mass index; DBP, diastolic blood pressure; FG, fasting glucose; HbA1c, glycated haemoglobin; non-HDLc, non-high-density lipoprotein cholesterol; OGTT2h, 2 h oral glucose tolerance test; SBP, systolic blood pressure; WC, waist circumference.
Table 2. Anthocyanin content of selected fruits and vegetables.
Table 2. Anthocyanin content of selected fruits and vegetables.
Fruit or VegetableFormAnthocyanin ContentSource
ChokeberryFresh fruit278.2–686.0 mg/100 g FW[49,69,70,71]
Pomace1602.0–6280.0 mg/100 g DW[68,72]
171.1 mg/100 g[73]
Juice38.8–1118.0 mg/L[74,75]
808.0–1527.0 mg CGE/L[68]
Syrup188 mg/L[75]
Fruit tea479.0–1557.0/100 g DW[68]
Extract9360 mg/100 g[55]
233.5 mg/L[60]
14,733.5 mg/kg FW[56]
BilberryFresh fruit0.34–0.47 mg/100 g[76]
2878 mg/100 g DW[77]
329.0 mg CGE/100 g FW[78]
0.041–0.166 μg/mL[79]
Extract1.89–5.57%[80]
BlackberryFresh fruit48.1–122.8 mg/100 g FW[81,82]
79.59–465.4 mg CGE/100 g FW[51]
Frozen fruit46.1–118.5 mg/100 g FW[82]
Dried fruit113.08–3924.2 CGE/100 g DW[83]
Extract5.3–4.5 mg/100 mL[84]
BlackcurrantFresh fruit62.8–287.8 mg CGE/100 g[50,85]
113.8 mg/100 g[81]
Lyophilised163.1 mg/100 g DW[86]
Frozen fruit183.0–446.0 mg CGE/100 g[87]
Juice1529.0–2083.0 mg/L[88]
Pomace55.1 mg/100 g[89]
Extract86.0–340.0 mg/L[90]
BlueberryFresh fruit0.1–534.2 mg/100 g[54,76,81,91,92]
Dried powder45,918.0 mg/100 g[91]
Juice3909.0 mg/mL[93]
Extract1301.2 mg/100 g FW[56]
5.8–11.4 mg/mL[84]
CherryFresh fruit0.2–344.9 mg/100 g[53,94]
20.0–120.0 mg CGE/100 g[95]
Extract117.2 mg/100 g FW[56]
19.9 mg CGE/100 g DW[96]
CranberryFresh fruit44.6–835.2 mg/100 g[48,97,98]
Juice0.398 mg/mL[93]
Extract520.0 mg/100 g[57]
ElderberryPomace30,500 mg/100 g DW[99]
Juice1090 mg/L[100]
Extract443.6–1413.8 mg/100 g FW[56,101]
RaspberryFresh fruit37.5–2199.0 mg/100 g[47,81,102,103]
12.0–325.5 mg CGE/100 g FW[51]
9.3 mg/100 g of dry material[104]
97.3 μM/100 g[105]
Lyophilised0.0–314.2 mg/100 g DW[86]
Juice powder1.5–2.5 g/100 g[106]
Extract67.1 mg/100 g[56]
2.3–3.7 mg/100 mL[84]
Red currantFresh fruit5.0–19.3 mg/100 g[81,107]
12.1–22.1 mg CGE/100 g[50]
Frozen fruit10.7–28.4 mg/100 g[107]
Juice5.8–25.6 mg/100 g[107]
Extract1.8–6.8 g/L[90]
StrawberryFresh fruit31.0–189.0 mg/100 g FW[61,62]
145.8–204.3 mg/100 g DW[52]
Extract16.6 mg/100 g FW[56]
38.0 mg CGE/100 g fruit[108]
0.7–1.1 mg/100 mL[84]
EggplantFresh vegetable0.01–72.4 mg/100 g[109]
Frozen pulp3.2–6.2 × 105 mg Del-3-glc/100 g FW[110]
Peel0.04–112.2 mg/100 g[109]
Frozen peel1208.1– 84,652.0 mg Del-3-glc/100 g FW[110]
Extract0.5–3.8 mg/100 mL[84]
Red cabbageFresh vegetable23.2–275.4 mg/100 g FW[58,111]
1111.0–1780.0 mg CGE/100 g DW[112]
16.0–889.0 μg/mL[113]
Extract24.7–191.4 mg/100 g[59]
1.0–547.3 mg/L[111,114,115,116]
14.5–89.2 mg CGE/g FW[117]
Red kidney beanFresh vegetable8.1–10.5 mg/100 g[118]
Peel/seed coat0.1–0.5 mg/g[119]
0.0–2.8 mg/g dried seed[120]
Extract39.6–40.8 mg/100 g[121]
Red onionFresh vegetable28.7–103.0 μg/g FW[122,123,124]
1.6–1.8 mg CGE/g DW[125]
Extract17.9 mg/L[126]
Abbreviations: CGE, cyanidin-3-glucoside equivalents; Del-3-glc, delphinidin-3-glucoside equivalents; DW, dry weight; FW, fresh weight.
Table 4. The effects of anthocyanins on the components of metabolic syndrome (in vivo studies in animal models).
Table 4. The effects of anthocyanins on the components of metabolic syndrome (in vivo studies in animal models).
Ref.Study GroupDaily IntakePeriod of ConsumptionEffect on the Body
[151]Spontaneously hypertensive ratsPurple corn, purple sweet potato and red radish (1 mass% of diets)15 weeks↓ SBP and HR
[152]Diet-induced obese miceNorton grape pomace extract (250 mg/kg bw)12 weeks↓ hsCRP;
no effect on
oxidative stress
[153]HamstersMulberry aqueous extracts12 weeks↓ Body weight, visceral fat, TG, free fatty acids and hepatic lipids
[154]Obese miceCombination of mulberry leaf extract (MLE) and mulberry fruit extract (MFE):
133 mg/kg bw or 333 mg/kg bw MLE
or 133 mg MLE and 67 mg MFE/kg bw
or 333 mg MLE and 167 mg MFE/kg bw
12 weeks↓ TG, liver lipid peroxidation and adipocyte size;
improvement in hepatic
steatosis, body weight gain, fasting plasma glucose and insulin, hsCRP, TNF-α and IL-1 in liver and adipose tissue
[155]24 adult male Wistar ratsHoneysuckle berry extract (2 g/kg bw)4 weeks↑ Bacterial α-glucosidase and
β-glucosidase activity;
normalisation of plasma
TG and insulin levels as well as insulin resistance
[156]Obese Zucker ratsDiet with 8% wild blueberries8 weeks↓ TNF-α, IL-6 and hsCRP;
↑ adiponectin
[157]Mice fed a high-fat dietHoneysuckle anthocyanins (50, 100 or 200 mg/kg bw)8 weeksHoneysuckle anthocyanins at 100 or 200 mg/kg bw:
suppression of body weight gain;
↓ serum and liver lipids, insulin and leptin;
↑ adiponectin
[158]Mice fed a high-fat dietSweet potato20 weeksImprovement in fasting blood glucose as well as glucose and insulin tolerance;
suppression of ROS;
restoration of antioxidant
enzyme activities
[159]Rabbits fed 1% cholesterolCornelian cherry (100 mg/kg bw)60 days↓ Serum TG and
proinflammatory cytokine levels;
↑ PPARα protein expression in the liver
[160]18 male Wistar rats25 mL of black chokeberry (Aronia melanocarpa) juice90 days↓ TC, LDLc and
atherogenic risk
[161]Sprague Dawley rats100 or 300 mg/kg bw blackcurrant (Ribes nigrum)8 weeksSuppression of increased liver weight and epididymal fat weight, oral glucose
tolerance and expression IRS-1 and p-AMPK in
muscle;
↓ hsCRP, total bilirubin,
leptin, insulin, TC, TG and LDLc
[162]Rabbits fed 1% cholesterolLoganic acid (20 mg/kg bw) or a mixture of anthocyanins (10 mg/kg bw)60 daysLoganic acid or anthocyanin mixture:
↓ TC, LDLc, TG and
ox-LDL in the plasma
↑ HDLc;
loganic acid alone:
↓ TNF-α and IL-6;
anthocyanin mixture alone:
↑ PPARγ and PPARα in the liver
[163]60 miceCherry and mulberry anthocyanins (200 mg/kg bw)8 weeks↓ Body weight gain, serum glucose, leptin and TNFα and IL-6 expression;
↑ SOD and GSH-PX activities;
[164]Obesity induced in C57BL/6 mice by feeding a high-fat dietBlack rice, black soybean or purple corn anthocyanins (200 mg/kg bw)12 weeks↓ body weight and TNF-α and IL-6 expression;
↑ faecal butyric acid levels and SOD and GSH-PX activities
[165]Spontaneously hypertensive ratsNormal diet with 10% freeze-dried aronia berries28 daysInhibition of the kidney renin–angiotensin system;
↓ BP;
no effect on body weight
[166]Wistar ratsCranberry extract
(200 mg/kg bw)
30 days↓ Body mass gain, TG,
corticosterone, hepatic cholesterol and fatty acid synthase;
↓ lipid peroxidation, protein carbonylation (liver and
adipose tissue) and
accumulation of fat in the liver
[167]Streptozotocin-induced diabetic ratsRed cabbage extract (800 mg/kg bw)4 weeks↓ Blood glucose;
↓ glycated and foetal
Haemoglobin;
improvement in glucose tolerance;
↑ serum insulin, proinsulin C-peptide and the number of pancreatic β-cells
[168]High-cholesterol-diet-induced hypercholesterolaemic miceExtract with lingonberry anthocyanins10 weeks↓ Body weight, daily food intake, liver weight, visceral adipose content, TC, LDLc and fasting blood glucose;
↑ HDLc
[169]C57BL/6 miceRaspberry anthocyanins (200 mg/kg bw)12 weeks↓ Body weight gain and TNFα and IL-6 expression;
↑ faecal butyric acid levels and SOD and GSH-PX activities
[170]Zucker diabetic fatty ratsCornelian cherry (500 or 1000 mg/kg bw)10 weeksBoth doses:
no effect on HOMA-IR;
1000 mg/kg bw:
↓ glucose
[171]Rat model of type 1 diabetes mellitusCornelian cherry (20 mg/kg bw)14 days↓ Blood glucose;
↑ reduced glutathione;
improvement in glucose tolerance
[172]Hyperglycaemic ratsPurple sweet potatoes (50 or 100 mg/kg bw)35 days↓ MDA in the blood, liver and kidney; urea and creatinine levels; serum glutamate oxalacetate transaminase and glutamate pyruvate transaminase levels
[173]Streptozotocin-induced diabetic ratsPurple potato (the Blue Congo variety) extract2 weeks↓ Blood glucose;
improvement in glucose tolerance;
↓ glycated haemoglobin and
MDA;
reinstatement of antioxidant enzyme activities
[174]C57BL/6J mice fed a high-fat dietBlack rice anthocyanins14 weeks↓ Body weight gain, TG, TC, steatosis scores and insulin resistance index
[175]C57BL/6J mice fed a high-fat dietBlackcurrant anthocyanins12 weeksAlleviated high-fat-diet-induced obesity, hyperlipaemia and
hepatic steatosis;
improvement in hepatic lipid metabolism
[176]C57BL/6J mice fed a high-fat dietPure water containing 0.8% of a crude extract of anthocyanins from Lycium ruthenicum fruit14 weeks↓ Body weight, TC and LDLc;
inhibition of lipid accumulation in liver and white adipose tissue and
pancreatic lipase activity;
regulation of the intestinal
microbiota
[177]Streptozotocin-
induced diabetic mice
100 and 400 mg/kg blueberry anthocyanin extracts5 weeks↓ Body weight, blood and urine glucose, TG and TC;
↑ AMPK activity
[178]Wistar rats(50, 100 or 200 mg/kg bw)4 weeks↓ SBP, DBP, MABP and HR
[179]Sprague Dawley ratsInfusion of anthocyanins (10 mg/kg bw, 0.4 μL/h)4 weeks↓ Caspase-1, IL-1β, TNF-α, ROS and BP
[180]Streptozotocin-
induced diabetic mice
Black bean peel extract (containing 40% anthocyanin, 400 mg/kg bw)4 weeks↑ T-AOC;
↓GSH
[181]C57BL/6J mice100, 400, or 800 mg/kg bw blueberry anthocyanin extract0.1–12 h↑ T-AOC;
↓ MDA
[182]Wistar rats100, 200, 300 or 400 mg/kg bw of anthocyanin extract4 weeks↓ CAT, MDA, GSH-PX, SOD
[183]Dankin Hartley guinea pigsDiet with 8% blueberries75 days↓ TG, MDA
Abbreviations: BP, blood pressure; bw, body weight; CAT, catalase; GSH, glutathione; GSH-PX, glutathione peroxidase; HDLc, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance; HR, heart rate; hsCRP, high-sensitivity C-reactive protein; IL-1, interleukin-1; IL-6, interleukin-6; IRS-1, insulin receptor substrate-1; LDLc, low-density lipoprotein cholesterol; MABP, mean arterial blood pressure; MDA, malondialdehyde; ox-LDL, oxidised low-density lipoprotein; p-AMPK, phosphorylated AMP-activated protein kinase; PPARα, peroxisome proliferator-activated receptor α; PPARγ, peroxisome proliferator-activated receptor γ; ROS, reactive oxygen species; SBP, systolic blood pressure; SOD, superoxide dismutase; T-AOC, total antioxidative capability; TC, total cholesterol; TG, triglycerides; TNF-α, tumour necrosis factor α; ↓, lowering the concentration; ↑, increase the concentration.
Table 5. The effects of anthocyanins and their supplementation on the components of metabolic syndrome (in vivo studies with humans).
Table 5. The effects of anthocyanins and their supplementation on the components of metabolic syndrome (in vivo studies with humans).
Ref.Study GroupDaily IntakePeriod of ConsumptionEffect on the Body
[195]48 people with MetS480 mL of water with vanilla extract and 50 g of freeze-dried blueberries8 weeks↓ SBP, DBP, oxidised LDLc,
MDA and hydroxynonenal;
no effect on glucose levels and the lipid profile
[196]36 people with MetS480 mL of cranberry juice8 weeks↑ Plasma antioxidant capacity;
↓ oxidised LDL and malondialdehyde
[197]40 children with dyslipidaemia (9–16 years old)50 g of Cornus mas L. fruit6 weeks↑ HDLc and apo A-I;
↓TC, LDLc, TG and apo B
[198]16 women with obesity and normal lipid and inflammatory marker levelsDried purple carrot delivering 118.5 mg/day of anthocyanins and 259.2 mg/day of phenolic acids4 weeks↓ HDLc;
no effect on body mass, body composition, TC, LDLc, BP and CRP
[199]60 people with abdominal
adiposity and
elevated serum
lipids
25 or 50 g of freeze-dried strawberries
reconstituted in 2 cups (474 mL) of water
12 weeks↓ TC and LDLc;
no effect on measures of adiposity, BP, glycaemia, HDLc, TG and CRP
[200]72 people with dyslipidaemia300 mL/day of blackberry juice with pulp8 weeks↑ HDLc and SBP;
↓ hsCRP
[201]58 people with diabetes mellitusSupplementation with 320 mg of anthocyanins24 weeks↑ HDLc and TRAP;
↓ LDLc, TG,
HOMA-IR,
IL-6 and TNF-α
[202]56 people with a BMI of 20–38 kg/m2 and in basic good health240 mL of low-calorie cranberry juice8 weeks↓ TG, CRP, DBP, FBG and HOMA-IR
[203]74 people with NAFLDPurified anthocyanins (320 mg/day) from bilberry and blackcurrant12 weeks↓ FBG and HOMA-IR
[204]36 apparently healthy people (25 men and 11 women)150 g of frozen bilberries (Vaccinium myrtillus L.) 3 times per week6 weeksMen and women:
↑ HDLc;
↓ TG, glucose,
albumin, aspartate aminotransferase and
γ-glutamyltransferase;
men only:
↑ LDLc;
women only:
↓ LDLc
[205]63 people with BMI >23 kg/m2
or WC > 90 cm (for men) or >85 cm (for women)
2.5 g/day of black soybean testa extracts8 weeks↓ WC; hip circumference; TG; LDLc; non-HDLc; and
arteriosclerosis indicators such as (TC)/HDLc and LDLc/HDLc
[206]11 women with overweight or obesity500 mL of commercial pasteurised red orange juice (250 mg of anthocyanins/day)12 weeks↓ TC and LDLc;
no effect on weight loss
[207]41 people with overweight or obesity (BMI ≥ 25 kg/m2) with
insulin resistance (fasting plasma insulin level
>60 pmol/L)
Beverage with 1.84 g of a mixture of dry strawberry (Fragaria × ananassa Duch) and cranberry (Vaccinium macrocarpon L.) (333 mg of polyphenol)6 weeks↑ Insulin sensitivity based on the
hyperinsulinaemic–euglycaemic clamp and C-peptide;
no effect on the lipid profile and markers of inflammation and oxidative stress
[208]49 healthy adult former smokers500 mg of chokeberry extract12 weeks↓ TC, LDLc;
no effect on BP and biomarkers of inflammation and
oxidative stress
[209]27 men with overweight or obesity (BMI > 25 kg/m2)High-fat diet (40% of energy from fat) that contained 600 g/day blackberries (~1476 mg of flavonoids and ~361 mg of total
anthocyanins per day)
1 week↓ iAUC for insulin;
↑ AUC for NEFAs
[210]115 adults with overweight or obesity (BMI ≥ 25 kg/m2)0.5 or 1 cup blueberries/day (182 or 364 mg of anthocyanins and 439 or 879 mg phenolics, respectively)6 weeks↑ HDLc;
no effect on TC, LDLc, HOMA-IR, HbA1c and BP
[211]50 healthy people (36 women and 14 men)300 mL/day of a 50%/50% mixture of berry and apple juice21 daysMen and women:
↑ HDLc and total
antioxidant status;
men only:
↓ TC and LDLc
[212]84 people ‘at cardiovascular risk’100 mL/day of chokeberry juice with a
high or low dose of polyphenols
(177.11 or 294.28 mg total polyphenols and 113.3 mg/100 mL or 28.3 mg/100 mL total
cyanidin-3-glucoside equivalents, respectively)
4 weeks↑ SFAs;
PUFAs;
no effect on TC, LDLc, SBP and DBP
[213]25 people with overweight (BMI  > 25 kg/m2)New Zealand blackcurrant extract
(600 mg/day)
8 days↓ hsCRP;
improvement in circulating insulin
[214]55 people with MetSSupplementation with 320 mg of anthocyanins4 weeksMen and women:
↓ FBG, TG and LDLc;
women only:
↓ CRP;
no effect on uric acid and HDLc
[215]35 women and men (with MetS or healthy)Veg-encapsulated anthocyanin extract taken two times a day (320 mg of anthocyanins)4 weeks↑ PPAR-γ and SOD gene expression;
↓ hsCRP and the
expression of NF-κB-dependent genes (TNF-α, IL-6 and IL-1α)
[216]18 people with NAFLD20 mL/day of cornelian cherry fruit
extract as liquid form (32 mg total
anthocyanins)
12 weeksNo effect on LAP, AIP, CRI and AC
[217]50 people with type 2 diabetes mellitus or
hypertension
Two 300 mg capsules of anthocyanin extract (total of 600 mg/day)30 days↓ hsCRP;
no effect on BP and blood glucose levels
[218]36 adults with features of metabolic syndrome480 mL cranberry juice (24 mg total anthocyanins)8 weeks↓ ox-LDL and MDA;
↑ antioxidant capacity in plasma;
no effect on biomarkers of inflammation, glucose and lipids
[219]30 healthy females330 mL juice or smoothie (total phenolics: juice—3227; smoothie—3435 mg/L)14 days↓ MDA;
no effect on IL-2, IL-6, IL-8 and IL-10, CRP, TNF-α, SOD and GSH-PX
Abbreviations: AC, atherogenic coefficient; AIP, atherogenic index of plasma; apo A-I, apolipoprotein A-I; apo B, apolipoprotein B; AUC, area under the curve; BMI, body mass index; BP, blood pressure; CRI, Castelli risk index I; CRP, C-reactive protein; DBP, diastolic blood pressure; FBG, fasting blood glucose; HbA1c, glycated haemoglobin; HDLc, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment for insulin resistance; hsCRP, high-sensitivity C-reactive protein; iAUC, incremental area under the curve; IL-1α, interleukin 1α; IL-6, interleukin-6; LAP, lipid accumulation product; LDLc, low-density lipoprotein cholesterol; MDA, malondialdehyde; MetS, metabolic syndrome; NAFLD, non-alcoholic fatty liver disease; NEFAs, non-esterified fatty acids; non-HDLc, non-high-density lipoprotein cholesterol; ox-LDL, oxidised low-density lipoprotein; PPARγ, peroxisome proliferator-activated receptor γ; PUFAs, polyunsaturated fatty acids; SBP, systolic blood pressure; SFAs, saturated fatty acids; SOD, superoxide dismutase; TC, total cholesterol; TGs, triglycerides; TNF-α, tumour necrosis factor α; TRAP, tartrate-resistant acid phosphatase; WC, waist circumference; ↓, lowering the concentration; ↑, increase the concentration.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Godyla-Jabłoński, M.; Raczkowska, E.; Jodkowska, A.; Kucharska, A.Z.; Sozański, T.; Bronkowska, M. Effects of Anthocyanins on Components of Metabolic Syndrome—A Review. Nutrients 2024, 16, 1103. https://doi.org/10.3390/nu16081103

AMA Style

Godyla-Jabłoński M, Raczkowska E, Jodkowska A, Kucharska AZ, Sozański T, Bronkowska M. Effects of Anthocyanins on Components of Metabolic Syndrome—A Review. Nutrients. 2024; 16(8):1103. https://doi.org/10.3390/nu16081103

Chicago/Turabian Style

Godyla-Jabłoński, Michaela, Ewa Raczkowska, Anna Jodkowska, Alicja Zofia Kucharska, Tomasz Sozański, and Monika Bronkowska. 2024. "Effects of Anthocyanins on Components of Metabolic Syndrome—A Review" Nutrients 16, no. 8: 1103. https://doi.org/10.3390/nu16081103

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop